Celanese Corp 8-K, filed Mar 25, 2021
Celanese Corp (CE)
8-K
2021-03-25
For: 2021-03-25
View Original
Added on
April 12, 2026
About this 8-K
Celanese Corp filed this 8-K on March 25, 2021.
Items reported
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 25, 2021
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||||||||
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (972 ) 443-4000
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Securities registered pursuant to Section 12(b) of the Act:
| Title of Each Class | Trading Symbol(s) | Name of Each Exchange on Which Registered | ||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
1
Item 7.01 Regulation FD Disclosure*
As previously announced, on March 25, 2021, Celanese Corporation (the "Company") will host a virtual Investor Day via live webcast. Chairman and Chief Executive Officer Lori Ryerkerk and other members of the Company's executive management team will provide information on the Company's business strategies and anticipated long-term growth drivers. The presentations will begin at 9:00 a.m., and will conclude at approximately 12:00 p.m., Eastern time, and will be available by webcast live on investors.celanese.com in the Events section. Access to the materials and a replay of the presentations will be available on the website for at least six months after the event.
The Company issued a press release in advance of the investor conference with key highlights of the presentation a copy of which is attached to this Current Report on Form 8-K ("Current Report") as Exhibit 99.1A. The Company also issued a press release updating its 2021 financial outlook for adjusted earnings per share, which is attached to this Current Report as Exhibit 99.1B.
Copies of the slide presentations that will be used during the presentation are attached to this Current Report as Exhibit 99.2. The press releases, slide presentations and oral remarks made in connection with the presentations refer to Non-US GAAP financial measures. Information about the measures used, including definitions and reconciliations to the most comparable US GAAP information, is attached to this Current Report as Exhibit 99.3. The documents attached as Exhibits 99.1, 99.2 and 99.3 are incorporated by reference herein solely for purposes of this Item 7.01 disclosure.
Item 9.01 Financial Statements and Exhibits
(d) The following exhibits are being furnished herewith:
| Exhibit Number | ||||||||
Description | ||||||||
| 104 | Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document contained in Exhibit 101). | |||||||
* In connection with the disclosure set forth in Item 7.01, the information in this Current Report, including the exhibits attached hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of such section. The information in this Current Report, including the exhibits, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any incorporation by reference language in any such filing. This Current Report will not be deemed an admission as to the materiality of any information in this Current Report that is required to be disclosed solely by Regulation FD.
2
CELANESE CORPORATION | |||||||||||
| By: | /s/ MICHAEL R. SULLIVAN | ||||||||||
| Name: | Michael R. Sullivan | ||||||||||
| Title: | Vice President, Deputy General Counsel and Assistant Corporate Secretary | ||||||||||
| Date: | March 25, 2021 | ||||||||||
3
Exhibit 99.1A
| Celanese Corporation | |||||
| 222 West Las Colinas Blvd. | |||||
| Suite 900N | |||||
| Irving, Texas 75039 | |||||
Celanese Corporation Outlines 2023 Growth Strategy and
Outlook at Investor Day
Dallas, March 25, 2021: Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, will host a virtual Investor Day beginning at 9 a.m. Eastern time today from Dallas. Chairman of the Board and Chief Executive Officer, Lori Ryerkerk, and other members of Celanese's executive management team will provide details on the Company's business strategies and outline the path for growth through 2023.
"Over the last decade, Celanese has advanced on a path to build unparalleled competitive positions, implement unique business models, and ingrain commercial excellence across the organization," said Ryerkerk. "We have systematically elevated the fundamental earnings and cash generation profile of the Company over this time. As a result, Celanese has generated a total shareholder return (TSR) of 271 percent1 over the last decade and delivered positive TSR in nine of the last ten years. Additionally, we have returned a total of $6.2 billion in cash to our shareholders over the last decade through share repurchases and dividends."
Ryerkerk continued, "Our businesses have demonstrated an ability to deliver resilient and strong performance in all environments. Following a challenging 2020 global backdrop, we entered 2021 with tremendous momentum across our businesses. Today, we will outline how we are enhancing Celanese's strategy to multiply this momentum and deliver double-digit earnings per share growth annually."
Acetyl Chain
John Fotheringham, Senior Vice President, will outline the strategic actions taken over the last decade to build out the Acetyl Chain's operating flexibility with regards to product, end market, feedstock, and geography. The business implemented a unique business model to optimize its unmatched optionality and has since delivered a series of earnings and margin profile improvements.
"We will highlight actions we are taking in the Acetyl Chain to layer on additional flexibility across our global network and more dynamically operate our business daily," said Fotheringham. "In addition to the acetic acid expansion at Clear Lake, we have a number of debottlenecks and capacity additions across our product portfolio to drive continued earnings growth."
The Acetyl Chain is expected to deliver adjusted EBIT of $900 to $1,000 million in 2023.
1 December 31, 2010 - December 31, 2020
1
Engineered Materials
Tom Kelly, Senior Vice President, will discuss the breadth of the Engineered Materials' solution set and the evolution in how the business meets customers' needs. Engineered Materials is expected to deliver above market volume and earnings growth driven by project model enhancements and focused programs to target high-growth applications like electric vehicles, medical and pharma, 5G, and sustainability. The business continues to invest in incremental capacity expansions across its network including further investment in Asia to support local innovation.
"Beyond strengthening our project pipeline model to build further scale and improve our winning percentage, we have dedicated resources to key programs to drive early wins with customer partners in disruptive and innovative applications," said Kelly. "These programs are already contributing to our growth and allow us to gain early advantages in areas that will determine material selection for years to come."
Engineered Materials is expected to deliver adjusted EBIT of $700 to $750 million in 2023.
Acetate Tow
Lori Ryerkerk will discuss the stable earnings profile of Acetate Tow, with strong contributions from affiliates and continued productivity in the business offsetting the impact of a steady decline in secular demand.
Acetate Tow is expected to deliver a stable adjusted EBIT of approximately $245 million through 2023.
Sustainability
Ryerkerk will also discuss Celanese's approach to sustainability, the development of a company ESG Council, and recent improvements to the Company's reporting and disclosure across multiple focus areas. She will also highlight several recent initiatives focused on important environmental and societal priorities as well as a growing portfolio of products to meet rising demand for sustainable solutions.
Financial Overview
Scott Richardson, Chief Financial Officer, will discuss how Celanese's approach to balanced capital allocation has driven consistent shareholder value creation over the last decade. Under the current strategic outlook, the Company expects to continue to deliver double-digit adjusted earnings per share growth on an annualized basis. The current financial outlook period will extend through 2023, culminating with expected adjusted earnings per share of $13.00 to $14.00 per share in 2023. Over this three-year period, the Company expects to generate a total of $4 to $5 billion in operating cash flow to be deployed to drive growth.
"We are accelerating our capital deployment cycle to allocate greater capital to our highest return organic opportunities," said Richardson. "We remain committed to returning cash to our shareholders via dividends, which we expect to grow in line with future earnings, as well as share repurchases. Given robust cash generation and the strength of the Celanese balance sheet, we anticipate flexibility to deploy up to $6 billion towards other capital allocation priorities including high-return M&A and share repurchases."
2
The event will begin at 9:00 a.m. Eastern time and will conclude at approximately 12:00 p.m. Details and access to the live event are available at https://investors.celanese.com under News & Events/Events Calendar.
Presentation materials will be available at https://investors.celanese.com at approximately 6:00 a.m. Eastern time today. Access to a replay of the presentations will be available on the website for six months following the event.
The Company is unable to reconcile adjusted earnings per share to US GAAP diluted earnings per share, or adjusted EBIT to net earnings (loss) attributable to Celanese Corporation, on a forward-looking basis without unreasonable efforts because a forecast of Certain Items, such as mark-to-market pension gains/losses, is not practical. For more information, see "Non-GAAP Financial Measures" below.
About Celanese
Celanese Corporation is a global chemical leader in the production of differentiated chemistry solutions and specialty materials used in most major industries and consumer applications. Our businesses use the full breadth of Celanese's global chemistry, technology and commercial expertise to create value for our customers, employees, shareholders and the corporation. As we partner with our customers to solve their most critical business needs, we strive to make a positive impact on our communities and the world through The Celanese Foundation. Based in Dallas, Celanese employs approximately 7,700 employees worldwide and had 2020 net sales of $5.7 billion. For more information about Celanese Corporation and its product offerings, visit www.celanese.com.
| Contacts: | ||||||||||||||
| Investor Relations | Media Relations - Global | Media Relations Europe (Germany) | ||||||||||||
| Brandon Ayache | W. Travis Jacobsen | Petra Czugler | ||||||||||||
| Phone: +1 972 443 8509 | Phone: +1 972 443 3750 | Phone: +49 69 45009 1206 | ||||||||||||
| brandon.ayache@celanese.com | william.jacobsen@celanese.com | petra.czugler@celanese.com | ||||||||||||
Forward-Looking Statements
This release may contain "forward-looking statements," which include information concerning the Company's plans, objectives, goals, strategies, future revenues, synergies, performance, capital expenditures, financing needs and other information that is not historical information. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the Company will realize these expectations or that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the results expressed or implied in the forward-looking statements contained in this release. These risks and uncertainties include, among other things: the extent to which the COVID-19 pandemic continues to adversely impact the economic environment, market demand and our operations, as well as the pace of any economic recovery; changes in general economic, business, political and regulatory conditions in the countries or regions in which we operate; the length and depth of product and industry business cycles, particularly in the automotive, electrical, mobility, textiles, medical, electronics and construction industries; changes in the price and availability of raw materials, particularly changes in the demand for, supply of, and market prices of ethylene, methanol, natural gas, wood pulp and fuel oil and the prices for electricity and other energy sources; the ability to pass increases in raw material prices on to customers or otherwise improve margins through price increases; the ability to maintain plant utilization rates and to implement planned capacity additions and expansions; the ability to reduce or maintain current levels of production costs and to improve productivity by implementing technological improvements to existing plants; the ability to identify desirable potential acquisition targets and to complete acquisition or investment transactions consistent with the Company's strategy; the ability to identify and execute on other attractive investment opportunities towards which to deploy capital; increased price competition and the introduction of competing products by other companies; market acceptance of our products and technology; compliance and other costs and potential disruption or interruption of production or operations due to accidents, interruptions in sources of raw materials, cyber security incidents, terrorism or political unrest, public health crises (including, but not limited to, the COVID-19 pandemic); other unforeseen events or delays in construction or operation of facilities, including as a result of geopolitical conditions, the occurrence of acts of war or terrorist incidents or as a result of weather or natural disasters or other crises including public health crises; the ability to obtain governmental approvals and to construct facilities on terms and schedules acceptable to the Company; changes in the degree of intellectual property and other legal protection afforded to our products or technologies, or the theft of such intellectual property; potential liability for remedial actions and increased costs under existing or future environmental, health and safety regulations, including those relating to climate change; potential liability resulting from pending or future litigation, or from changes in the laws, regulations or policies of governments or other governmental activities in the countries in which we operate; changes in currency exchange rates and interest rates; our level of indebtedness, which could diminish our ability to raise additional capital to fund operations or limit our ability to react to changes in the economy or the chemicals industry; tax rates and changes thereto; our ability to obtain regulatory approval for, and satisfy closing conditions to, any transactions described herein; and various other factors discussed from time to time in the Company's filings with the Securities and Exchange Commission.
3
The extent to which COVID-19 will adversely impact our business, financial condition and results of operations will depend on numerous evolving factors, which are highly uncertain, rapidly changing and cannot be predicted, including: the extent of any resurgence in infections and the spread of the disease, and the effectiveness of any vaccines; additional governmental, business and individual actions to contain the spread of the outbreak, including social distancing, work-at-home, stay-at-home and shelter-in-place orders and shutdowns, travel restrictions and quarantines; the extent to which these conditions depress economic activity generally and demand for our products specifically and affect the financial markets; the effect of the outbreak on our customers, suppliers, supply chain and other business partners; our ability during the outbreak to provide our products and services, including the health and well-being of our employees; business disruptions caused by actual or potential plant, workplace and office closures; the risk that we could be exposed to liability, negative publicity or reputational harm related to any incidents of actual or perceived transmission of COVID-19 among employees at our facilities; the ability of our customers to pay for our products and services during and following the outbreak; the impact of the outbreak on the financial markets and economic activity generally; our ability to access usual sources of liquidity on reasonable terms; and our ability to comply with the financial covenant in our Credit Agreement if a material and prolonged economic downturn results in increased indebtedness or substantially lower EBITDA.
Any forward-looking statement speaks only as of the date on which it is made, and the Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances.
Non-GAAP Financial Measures
Presentation
This document presents the Company's three business segments, Engineered Materials, Acetate Tow and Acetyl Chain.
Use of Non-US GAAP Financial Information
This release uses the following Non-US GAAP measures: adjusted EBIT and adjusted earnings per share. These measures are not recognized in accordance with US GAAP and should not be viewed as an alternative to US GAAP measures of performance or liquidity. The most directly comparable financial measure presented in accordance with US GAAP in our consolidated financial statements for adjusted EBIT is net earnings (loss) attributable to Celanese Corporation and for adjusted earnings per share is earnings (loss) from continuing operations attributable to Celanese Corporation per common share-diluted.
Definitions of Non-US GAAP Financial Measures
•Adjusted EBIT is a performance measure used by the Company and is defined by the Company as net earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income, plus interest expense, plus refinancing expense and taxes, and further adjusted for Certain Items (refer to Table 8 of our Non-US GAAP Financial Measures and Supplemental Information document). We do not provide reconciliations for adjusted EBIT on a forward-looking basis (including those contained in this document) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of Certain Items, such as mark-to-market pension gains and losses, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information.
•Adjusted earnings per share is a performance measure used by the Company and is defined by the Company as earnings (loss) from continuing operations attributable to Celanese Corporation, adjusted for income tax (provision) benefit, Certain Items, and refinancing and related expenses, divided by the number of basic common shares and dilutive restricted stock units and stock options calculated using the treasury method. We do not provide reconciliations for adjusted earnings per share on a forward-looking basis (including those contained in this document) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of Certain Items, such as mark-to-market pension gains and losses, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information.
Note: The income tax expense (benefit) on Certain Items ("Non-GAAP adjustments") is determined using the applicable rates in the taxing jurisdictions in which the Non-GAAP adjustments occurred and includes both current and deferred income tax expense (benefit). The income tax rate used for adjusted earnings per share approximates the midpoint in a range of forecasted tax rates for the year. This range may include certain partial or full-year forecasted tax opportunities and related costs, where applicable, and specifically excludes changes in uncertain tax positions, discrete recognition of GAAP items on a quarterly basis, other pre-tax items adjusted out of our GAAP earnings for adjusted earnings per share purposes and changes in management's assessments regarding the ability to realize deferred tax assets for GAAP. In determining the adjusted earnings per share tax rate, we reflect the impact of foreign tax credits when utilized, or expected to be utilized, absent discrete events impacting the timing of foreign tax credit utilization. We analyze this rate quarterly and adjust it if there is a material change in the range of forecasted tax rates; an updated forecast would not necessarily result in a change to our tax rate used for adjusted earnings per share. The adjusted tax rate is an estimate and may differ from the actual tax rate used for GAAP reporting in any given reporting period. Table 3a of our Non-US GAAP Financial Measures and Supplemental Information document summarizes the reconciliation of our estimated GAAP effective tax rate to the adjusted tax rate. The estimated GAAP rate excludes discrete recognition of GAAP items due to our inability to forecast such items. As part of the year-end reconciliation, we will update the reconciliation of the GAAP effective tax rate to the adjusted tax rate for actual results.
Reconciliation of Non-US GAAP Financial Measures
Refer to Exhibits 99.3A and 99.3B of the accompanying Form 8-K, and which are also available on the Investor Relations/Financial Information/Non-GAAP Financial Measures page of our website, www.celanese.com, for additional definitions and reconciliations of non-GAAP financial measures.
4
Exhibit 99.1B
| Celanese Corporation | |||||
| 222 West Las Colinas Blvd. | |||||
| Suite 900N | |||||
| Irving, Texas 75039 | |||||
Celanese Corporation Increases 2021 Financial Outlook
Dallas, March 24, 2021: Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today increased its full year 2021 outlook for adjusted earnings of $11.00 to $11.50 per share. The midpoint of the new guidance range represents a 15 percent increase over the prior range of $9.50 to $10.00.
"While Winter Storm Uri had an unprecedented impact on Texas and our gulf coast operations, I am pleased to share that our Clear Lake, Bishop, and Bay City facilities are all operational with most units producing at pre-storm levels", said Lori Ryerkerk, chairman and chief executive officer. "Amid tightened market conditions following Winter Storm Uri, we expect a strong finish to the first quarter with adjusted earnings around $3.00 per share. We expect momentum to continue across the middle of 2021 as we meet elevated demand for our Acetyl Chain and Engineered Materials products. By accelerating major turnarounds from 2021 into 2020, we are uniquely positioned to reliably supply markets which we expect will remain tight into the middle of the year following the winter storm."
The Company is unable to reconcile adjusted earnings per share to US GAAP diluted earnings per share on a forward-looking basis without unreasonable efforts because a forecast of Certain Items, such as mark-to-market pension gains/losses, is not practical. For more information, see "Non-GAAP Financial Measures" below.
About Celanese
Celanese Corporation is a global chemical leader in the production of differentiated chemistry solutions and specialty materials used in most major industries and consumer applications. Our businesses use the full breadth of Celanese's global chemistry, technology and commercial expertise to create value for our customers, employees, shareholders and the corporation. As we partner with our customers to solve their most critical business needs, we strive to make a positive impact on our communities and the world through The Celanese Foundation. Based in Dallas, Celanese employs approximately 7,700 employees worldwide and had 2020 net sales of $5.7 billion. For more information about Celanese Corporation and its product offerings, visit www.celanese.com.
| Contacts: | ||||||||||||||
| Investor Relations | Media Relations - Global | Media Relations Europe (Germany) | ||||||||||||
| Brandon Ayache | W. Travis Jacobsen | Petra Czugler | ||||||||||||
| Phone: +1 972 443 8509 | Phone: +1 972 443 3750 | Phone: +49 69 45009 1206 | ||||||||||||
| brandon.ayache@celanese.com | william.jacobsen@celanese.com | petra.czugler@celanese.com | ||||||||||||
1
Forward-Looking Statements
This release may contain "forward-looking statements," which include information concerning the Company's plans, objectives, goals, strategies, future earnings, revenues or performance, capital expenditures, and other information that is not historical information. When used in this release, the words "outlook," "forecast," "estimates," "expects," "anticipates", "projects," "plans," "intends," "believes," and variations of such words or similar expressions are intended to identify forward-looking statements. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the Company or its customers will realize these benefits or that these expectations will prove correct. There are a number of risks and uncertainties, many of which are beyond the Company's control, that could cause actual results to differ materially from the forward-looking statements contained in this release. These risks and uncertainties include, among other things: the extent to which the COVID-19 pandemic continues to adversely impact the economic environment, market demand and our operations, as well as the pace of any economic recovery; the length and depth of product and industry business cycles, particularly in the automotive, electrical, textiles, electronics and construction industries; changes in the price and availability of raw materials, particularly changes in the demand for, supply of, and market prices of ethylene, methanol, natural gas, wood pulp and fuel oil and the prices for electricity and other energy sources; the ability to pass increases in raw material prices on to customers or otherwise improve margins through price increases; the ability to maintain plant utilization rates and to implement planned capacity additions and expansions as well as facility turnarounds; the ability to reduce or maintain their current levels of production costs and to improve productivity by implementing technological improvements to existing plants; the ability to identify desirable potential acquisition targets and to complete acquisition or investment transactions consistent with the Company's strategy; increased price competition and the introduction of competing products by other companies; market acceptance of our technology; compliance and other costs and potential disruption or interruption of production or operations due to accidents, interruptions in sources of raw materials, cyber security incidents, terrorism or political unrest, public health crises (including, but not limited to, the COVID-19 pandemic), or other unforeseen events or delays in construction or operation of facilities, including as a result of geopolitical conditions, the occurrence of acts of war or terrorist incidents or as a result of weather or natural disasters or other crises including public health crises; the ability to obtain governmental approvals and to construct facilities on terms and schedules acceptable to the Company; changes in tariffs, tax rates or legislation; changes in the degree of intellectual property and other legal protection afforded to our products or technologies, or the theft of such intellectual property; potential liability for remedial actions and increased costs under existing or future environmental, health and safety regulations, including those relating to climate change; potential liability resulting from pending or future litigation, or from changes in the laws, regulations or policies of governments or other governmental activities in the countries in which we operate; changes in currency exchange rates and interest rates; our level of indebtedness, which could diminish our ability to raise additional capital to fund operations or limit our ability to react to changes in the economy or the chemicals industry; and various other factors that are discussed in the Company's filings with the Securities and Exchange Commission.
Any forward-looking statement speaks only as of the date on which it is made, and the Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances.
Non-GAAP Financial Measures
This press release refers to adjusted earnings per share, which is a non-GAAP financial measure. This measure is not recognized in accordance with US GAAP and should not be viewed as an alternative to US GAAP measures of performance or liquidity. The most directly comparable financial measure presented in accordance with US GAAP in our consolidated financial statements for adjusted earnings per share is earnings (loss) from continuing operations attributable to Celanese Corporation per common share-diluted.
Adjusted earnings per share is a performance measure used by the Company and is defined by the Company as earnings (loss) from continuing operations attributable to Celanese Corporation, adjusted for income tax (provision) benefit, Certain Items, and refinancing and related expenses, divided by the number of basic common shares and dilutive restricted stock units and stock options calculated using the treasury method. We do not provide reconciliations for adjusted earnings per share on a forward-looking basis (including those contained in this document) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of Certain Items, such as mark-to-market pension gains and losses, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information.
Note: The income tax expense (benefit) on Certain Items ("Non-GAAP adjustments") is determined using the applicable rates in the taxing jurisdictions in which the Non-GAAP adjustments occurred and includes both current and deferred income tax expense (benefit). The income tax rate used for adjusted earnings per share approximates the midpoint in a range of forecasted tax rates for the year. This range may include certain partial or full-year forecasted tax opportunities and related costs, where applicable, and specifically excludes changes in uncertain tax positions, discrete recognition of GAAP items on a quarterly basis, other pre-tax items adjusted out of our GAAP earnings for adjusted earnings per share purposes and changes in management's assessments regarding the ability to realize deferred tax assets for GAAP. In determining the adjusted earnings per share tax rate, we reflect the impact of foreign tax credits when utilized, or expected to be utilized, absent discrete events impacting the timing of foreign tax credit utilization. We analyze this rate quarterly and adjust it if there is a material change in the range of forecasted tax rates; an updated forecast would not necessarily result in a change to our tax rate used for adjusted earnings per share. The adjusted tax rate is an estimate and may differ from the actual tax rate used for GAAP reporting in any given reporting period. Table 3a of our Non-US GAAP Financial Measures and Supplemental Information document summarizes the reconciliation of our estimated GAAP effective tax rate to the adjusted tax rate. The estimated GAAP rate excludes discrete recognition of GAAP items due to our inability to forecast such items. As part of the year-end reconciliation, we will update the reconciliation of the GAAP effective tax rate to the adjusted tax rate for actual results.
2
Disclosures Forward-Looking Statements This presentation contains "forward-looking statements," which include information concerning the Company's plans, objectives, goals, strategies, future revenues, synergies, performance, capital expenditures, financing needs and other information that is not historical information. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the Company will realize these expectations or that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the results expressed or implied in the forward-looking statements contained in this presentation. These risks and uncertainties include, among other things: the extent to which the COVID-19 pandemic continues to adversely impact the economic environment, market demand and our operations, as well as the pace of any economic recovery; changes in general economic, business, political and regulatory conditions in the countries or regions in which we operate; the length and depth of product and industry business cycles, particularly in the automotive, electrical, mobility, textiles, medical, electronics and construction industries; changes in the price and availability of raw materials, particularly changes in the demand for, supply of, and market prices of ethylene, methanol, natural gas, wood pulp and fuel oil and the prices for electricity and other energy sources; the ability to pass increases in raw material prices on to customers or otherwise improve margins through price increases; the ability to maintain plant utilization rates and to implement planned capacity additions and expansions; the ability to reduce or maintain current levels of production costs and to improve productivity by implementing technological improvements to existing plants; the ability to identify desirable potential acquisition targets and to complete acquisition or investment transactions consistent with the Company's strategy; the ability to identify and execute on other attractive investment opportunities towards which to deploy capital; increased price competition and the introduction of competing products by other companies; market acceptance of our products and technology; compliance and other costs and potential disruption or interruption of production or operations due to accidents, interruptions in sources of raw materials, cyber security incidents, terrorism or political unrest, public health crises (including, but not limited to, the COVID-19 pandemic); other unforeseen events or delays in construction or operation of facilities, including as a result of geopolitical conditions, the occurrence of acts of war or terrorist incidents or as a result of weather or natural disasters or other crises including public health crises; the ability to obtain governmental approvals and to construct facilities on terms and schedules acceptable to the Company; changes in the degree of intellectual property and other legal protection afforded to our products or technologies, or the theft of such intellectual property; potential liability for remedial actions and increased costs under existing or future environmental, health and safety regulations, including those relating to climate change; potential liability resulting from pending or future litigation, or from changes in the laws, regulations or policies of governments or other governmental activities in the countries in which we operate; changes in currency exchange rates and interest rates; our level of indebtedness, which could diminish our ability to raise additional capital to fund operations or limit our ability to react to changes in the economy or the chemicals industry; tax rates and changes thereto; our ability to obtain regulatory approval for, and satisfy closing conditions to, any transactions described herein; and various other factors discussed from time to time in the Company's filings with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made, and the Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. Results Unaudited The results in this document, together with the adjustments made to present the results on a comparable basis, have not been audited and are based on internal financial data furnished to management. Historical results should not be taken as an indication of the results of operations to be reported for any future period. Non-GAAP Financial Measures This presentation, and statements made in connection with this presentation, refer to non-GAAP financial measures. For more information on the non-GAAP financial measures used by the Company, including the most directly comparable GAAP financial measure for each non-GAAP financial measures used, including definitions and reconciliations of the differences between such non-GAAP financial measures and the comparable GAAP financial measures, please refer to the Non-US GAAP Financial Measures and Supplemental Information document available on our website, investors.celanese.com, under Financial Information/Non-GAAP Financial Measures. Market / Industry Information and Management Estimates This presentation includes market, economic, and industry data and forecasts. The Company obtained this information from industry publications, third party reports and management’s own internal estimates. Industry publications and other third-party surveys and forecasts generally state that the information contained therein has been obtained from sources believed to be reliable, but that the accuracy and completeness of such information is not guaranteed. While the Company believes that data included in this presentation from third-party sources is reasonably reliable as of the date of this presentation, the Company has not independently verified such data and cannot guarantee its accuracy or completeness. The Company also cannot guarantee the correctness of the assumptions underlying its internally-generated estimates or information. ~ Celanese
2021 Investor Day March 25, 2021
Welcome Lori Ryerkerk
2 Welcome & Introduction Lori Acetyl Chain (AC) John Engineered Materials (EM) Tom Break Acetate Tow (AT) Lori Sustainability Lori Financial Excellence Scott Wrap Up Lori Break Question & Answer Session Lori Ryerkerk Chairman & CEO Tom Kelly SVP, Engineered Materials Scott Richardson Chief Financial Officer John Fotheringham SVP, Acetyl Chain Agenda ~ Celanese ~ Celanese
…collectively focused on delivering value for shareholders Everything we do starts with our people… Celanese Values employees shareholders safety customers communityquality 3 ~ Celanese ~ Celanese
Commercial Excellence Enhanced … to sustainably lift the foundational earnings power of Celanese We have been on a path this decade… Competitive Positions & Financial Health Established 2011 2012 2013 2014 Differentiated Business Models Implemented 2015 2016 2017 2018 2019 2020 $4.51 $4.07 $4.50 $5.67 $6.02 $6.61 $7.51 $11.00 $9.53 $7.64 $4-6 $6-8 $8-10 Adjusted earnings per share 4 ~ Celanese ~ Celanese
14% lower Chinese acetic acid pricing lower Engineered Materials affiliate earnings higher turnaround expense 27% lower Q2 Engineered Materials volume … proved the resiliency of our earnings power and positioned us for recovery Decisive actions amid 2020 pandemic… 1 Headwinds versus 2019 2020 Actions $214 million in productivity $1.575 billion monetization of Polyplastics Elotex acquired and integrated Favorable long-term raw material agreements KEPCO JV restructuring commenced Acetic acid reconfiguration project improvements Accelerated turnarounds prior to recovery 2020 Headwinds1 $53M ~$70M 5 ~ Celanese ~ Celanese
Positioned to drive continued shareholder value Total Shareholder Return (February 28, 2011 - February 28, 2021) S&P 500 253% 161% Celanese Avg. Annual TSR 16.1% 13.9% 11.3% Celanese S&P 500 DJUSCH Index 6 Performance has delivered leading total shareholder return 296% DJUSCH Index ~ Celanese ~ Celanese
1 Themes you will hear today 8 FOCUSING OUR UNIQUE BUSINESS MODELS TO WIN IN KEY END MARKETS… ENGINEERED MATERIALS ACETYL CHAIN ACETATE TOW Dedicated growth programs Aligning early with industry winners Subsegments with differentiated growth Driving differentiation in downstream products Alternative uses for acetate flake Sustainability solutions ...to drive GDP+ growth in Engineered Materials and the Acetyl Chain MULTIPLYING OUR MOMENTi ~ ~ Celanese
2 Themes you will hear today TRANSFORMING OUR APPROACH TO PRODUCTIVITY … PROCESS AUTOMATION DATA & ANALYTICS SUPPLY CHAIN NETWORK Supply chain optimization tools Customer experience solutions Analytics & predictive forecasting Artificial intelligence for business decisions Regional production localization Scheduling upgrades ...to drive continued lift in fundamental profitability 9 MULTIPLYING OUR MOMENTi ~ ~ Celanese
SUPPLY CHAIN NETWORK 3 Themes you will hear today DRIVING GREATER SUSTAINABILITY... ENVIRONMENTAL SOCIETAL COMMERCIAL Energy & resource efficiency Climate change Diversity, equity & inclusion Community partnerships Sustainable feedstocks End-of-life product solutions ...consistent with our values and top tier shareholder value generation 10 MULTIPLYING OUR MOMENTi ~ ~ Celanese
4 Themes you will hear today ENHANCING OUR CASH GENERATION AND CAPITAL DEPLOYMENT... ORGANIC INVESTMENT INORGANIC INVESTMENT CASH TO SHAREHOLDERS High-return, capital-efficient expansions Productivity enhancing projects Attractive M&A opportunity sets Joint venture optimization Dividend growth Steady & opportunistic share repurchases ...while maintaining industry leading returns 11 MULTIPLYING OUR MOMENTi ~ ~ Celanese
Multiplying our momentum… …to deliver double-digit earnings per share growth annually Adjusted Earnings Per Share 2015 2016 2017 2018 2019 2020 2021F 2022F 2023F $6-8 $8-10 $11-14 3 2 1 4 Winning in key end markets Transforming our productivity Driving greater sustainability Enhancing our capital deployment 12 ADJUSTED EBIT $1.7-1.8B 2023 $9.53$11.00$7.51$6.61$6.02 $7.64 ADJUSTED EPS OPERATING CASH FLOW $13-14 2023 $4-5B Cumulative 2021-2023 MULTIPLYING OUR MOMENTi ~ ~ Celanese
Acetyl Chain John Fotheringham
Evolution of the Acetyl Chain business model... ...has doubled foundational earnings in the last decade Legacy Business Chain Implementation 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 0.3 Enhanced Flexibility Adjusted EBIT Adjusted EBIT margin 2008-2009 financial crisis 2 VAE footprint rationalizations VAM footprint rationalizations VAM footprint rationalizations Creation of “Acetyl Chain” business Start of Fairway Methanol JV 2018 market dislocation Clear Lake VAM expansion 2020 pandemic earnings exceed 2014-2017 avg. 14% 17% 25% 18% $450M - 600M $700M - 900M
Themes you will hear today 1 GLOBAL MANUFACTURING FOOTPRINT SERVICING A WIDE RANGE OFRESILIENT END USES 2 UNMATCHED VALUE CHAIN OPTIONALITY SUPPORTED BY LOWCOST TECHNOLOGY 3 HEALTHY INDUSTRY DYNAMICS WITH STRONG DEMAND GROWTH 4 TARGETED CAPITAL INVESTMENT SUPPORTING GROWING AND SUSTAINABLE END USES 3
Acetyls chemistry supports every day life Food & Agriculture Building & Construction Medical & Pharmaceutical Automotive & Industrials Packaging & Paper Food additives Thickening agents Crop protection Dust control Paints & coatings Cement additives Waterproofing External insulation Medicine production Disinfection & sterilization Cosmetics Hygiene Safety glass Inks & solvents Solar PV1 cells Glassfiber Adhesives Coatings Food packaging Surface protection 4 1PV - Photovoltaic
Industry-leading commercial diversity and flexibility... ...results in margins similar or higher than specialty materials Based on internal estimates 2018-2020 Average Net Sales: $3.5B BY PRODUCT BY REGION BY END USE Anhydride & Esters OtherAcetic Acid VAM 21 11 10 Paints & Coatings Adhesives Paper & Packaging Other Con stru ctio n Automotive Filtration Consumer Industrial Additives Textiles Food & Bev Americas Asia Europe Optionality range Emulsions 5
Globally integrated acetyls leader... ...creates unequaled market knowledge and optionality 1 Europe, Middle East, & Africa CARBON MONOXIDE METHANOL ACETIC ACID VAM EMULSIONS POWDERS AMERICAS EMEA1 ASIA 6 Competitor 1 Competitor 7 Competitor 5 Competitor 6 Competitor 3 Competitor 4 Competitor 2 Celanese
Unique value chain... Carbon Monoxide Methanol 1 1 Acetic Acid Anhydride & Esters Flexible entry into the market 2 VAM ~70% acid content 3 Emulsions ~30% acid content 4 Powders ~35% acid content 5 Legacy Acetyl Chain Extended Acetyl Chain ...enables flexible product placement and value optimization 7
Value creation through advantaged technology... ...enables capital efficiency and lowest cost to supply State-of-the-art process technology and intellectual property • Leading technologies with high efficiencies and flexibility 8 Low capital intensity for world-scale production facilities Proprietary catalyst technology for maximum yield and low metals usage Increase in VAM capacity per plant Increase in acid capacity per plant Better expansion capital efficiency vs. brownfield50% 40%90% • Continued growth across global footprint • Low-capital expansion options • Global catalyst and metals management program • R&D partnerships continue catalyst advancement since 2005 since 2005
Cost leadership in all scenarios... ...driven by feedstock optionality, scale and advantaged technology Acid Cost Curve With Low Oil Acid Cost Curve With High Oil C le ar L ak e S in ga po re N an jin g C le ar L ak e E xp an si on C le ar L ak e S in ga po re N an jin g Americas & EMEA AOC1 China Nominal global price setter Nominal global price setter C le ar L ak e E xp an si on Celanese 9 1 AOC - Asia Outside China
Leading cost positions in import markets Landed Europe Europe Based on internal estimates of average landed cost into key regions Celanese In-region producers Incremental importers Southeast Asia Landed Southeast Asia 10
Strong demand recovery... ...driving improved utilization Based on internal estimates 1 Utilization reflecting industry nameplate capacity at typical on-stream rates; includes impact of instantaneous outage activity. Capacity overbuild in Asia Short-term demand dislocation Recovery to healthy market conditions Improved utilization on demand growth D em an d (m il li on t on ne s) U ti li za ti on 80% 90% 70% 15 21 24 18 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021F 2022F 2023F Utilization1Acid + VAM Demand 11
Enhanced building and construction portfolio Solutions across every product of the chain VAM VAE RDP1 CE Product End Uses • VAE/powder derivatives • Adhesives • Powder derivatives • Adhesives • Paints & coatings • Cement enhancement • Tile grouts • Insulation & membranes • Repairs & upgrades Renders & Plasters Flooring Underlayment Repairs Paints & Coatings Tile Adhesive & Grouts External Thermal Insulation Composite Systems Cementitious Waterproofing Membranes 12 1RDP - Redispersible powders Solar PV Cells
Solar power accelerates Asia vinyls demand Solar PV cells require high quality EVA 15% solar CAGR from 2019 to 2030 Celanese can supply additional high quality VAM capacity at lowest capital requirements Based on International Energy Agency Main Case 2010-2022, Sustainable Development Scenario 2025 and internal estimates High Quality EVA and VAM Support Global PV Growth By 2023, annual solar capacity additions expected to consume 250 kt of VAM 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021F 2022F 2023F 2024F 13 0 100 200 300 0 50 100 150 200 250 300 S ol ar p ow er c ap ac it y ad di ti on s (G W ) 2025F V A M e qu iv al en t (k t) Solar power capacity additions (GW) VAM equivalent for solar capacity (kt)
...to increase base earnings, lower volatility and enable upside capture Q1 2019 2023GLOBAL ACID RECONFIGURATION: New Build at Clear Lake Q1 2021 2023METHANOL EXPANSION: Debottleneck at Clear Lake Q1 2020 2023VAE EMULSION EXPANSION: Debottleneck & New Build at Nanjing and Frankfurt Q1 2021 2022-2023VAM EXPANSION: Debottleneck at Nanjing Q1 2021 2021-2022POWDERS DEBOTTLENECKS: Debottlenecks of European Powders ONLINE PRODUCTIVITY DERIVITIZATION GROWTHANNOUNCED SUSTAINABILITY 3,300 kt 1,300 kt 3,500 kt 4,600 kt Current Clear Lake Expansion Produce to Demand Target Capacity Optionality 5% - 35% expanded capacity 1,575 kt 90 kt 100 kt 1,765 kt Current Nanjing Expansion Technology Debottlenecks Future Capacity 710 kt 20 kt 45 kt 65 kt 840 kt Current Europe Debottlenecks Frankfurt Expansion Nanjing Expansion Future Capacity VAM ~10% EMULSIONS ~20%ACETIC ACID Investing in high return projects... 14 expanded capacity expanded capacity
Enhanced acetic acid project positions for growth... CAPITAL EXPENDITURE ~$350M 1,000kt MANUFACTURING FLEXIBILITYANNUALIZED AVERAGE VALUE ~$100M INCREMENTAL CAPACITY 1,300kt Enhanced Asia flexibility with new supply contracts Retention of project value and supply optionality Clear Lake capital efficiency and productivity Lowered cost position relative to coal and oil Enhanced offtake flexibility improves global optionality Unparalleled capacity and raw material optionality ~$100M average earnings lift per year across project cycle Project extension enabled capital savings World-scale capacity with operating cost productivity Wide operating range to match market demand 15
16 Vinyls expansion program creates additional flexibility... VAM Expansion Nanjing NEW NANJING VAM CAPACITY90kt NEWEMULSIONSCAPACITY110kt POWDERS UTILIZATION GROWTH40kt Powders Growth Europe & Asia VAE Expansions Nanjing & Frankfurt Solar PV driving acute Asia growth in vinyls chain Proven record of capital efficient and technology- driven expansions Growing polymer powders penetration into mortar formulations Utilizing spare capacity to accelerate downstream growth Higher building standards, performance and sustainability Expanding existing global emulsions infrastructure
...within the Acetyl Chain and for our customers Focused on driving greater sustainability... Acetyl Chain Sustainability Pipeline Sustainable Sourcing CO2 Capture and Recycling Recycled Content • Clear Lake partial solar power supply • Bio-based renewable natural gas feedstock optionality • Clear Lake methanol from recycled CO2 • Certified recycled acetic acid can be sold directly to customers or derivatized downstream 17
Acetyl Chain financial outlook Resilient Global Markets ADJUSTED EBIT MARGIN >22% 2021-2023 >25% 2021-2023 OPERATING EBITDA MARGIN $568 ~$900 $900-1,000 2020 2021F 2023F NET SALES CAGR 5-6% 2019-2023 ADJUSTED EBIT CAGR 2019-2023 18% Adjusted EBIT margin Adjusted EBIT (in millions) 18 1 2 3 4 Unmatched Value Chain Optionality Healthy Industry Dynamics Targeted Capital Investment 5-8% $727 21% Adjusted EBIT margin 2019
Engineered Materials Tom Kelly
Improving the world and everyday life Electronics Automotive Medical Small Appliance Consumer Packaging Industrial 2
PROJECT PIPELINE MODEL CONTINUES TO DIFFERENTIATE EM; DIGITALIZATION STRENGTHENS THE MODEL BY INCREASING SCALABILITY, PREDICTABILITY GROWTH FOCUSED PROGRAMS IN FUTURE MOBILITY, MEDICAL AND CONNECTIVITY POSITION EM FOR OUTSIZED GROWTH AN EXPANDED PORTFOLIO OF SUSTAINABLE OFFERINGS ENABLES GROWTH IN EXISTING AND NEW END MARKETS Themes you will hear today 1 2 3 4 INVESTMENTS IN LOCALIZATION WILL CONTINUE TO SUPPORT DOUBLE-DIGIT GROWTH IN ASIA 3
A broad portfolio and application expertise… …drive outsized, innovation-led growth Automotive Broad Polymer Portfolio Industry Leading Technical Competencies 2020 Net Sales Formulation Development Part & Tool Design Prototyping Part Processing Testing & Analytical Customer Trials Application Development Industrial Consumer Electrical & Electronics Medical Food & Beverage Other Based on internal estimates 4 PEER 1 PEER 2 PEER 3 PEER 4 PEER 5 PEER 6 PEER 7 PEER 8 UNIVERSE OF ENGINEERED POLYMERS CELANESE ENGINEERED MATERIALS 25-30 >20 OF CE BREADTH OF CE BREADTH ~50% ~25%
…add to capabilities set and maximize shareholder value Strategic acquisitions and JV actions... HIGH GROWTH GEOGRAPHY SOLUTION SET KEY END MARKET EXPERTISE ENABLING COMPETENCIES NILIT Plastics Bolstered solution offering and global reach Reduced EM adjusted EBIT from affiliate earnings by half to ~15% Monetized passive investment for $1.6B Agreement to restructure as manufacturing JV; 70 kt of POM offtake Increased CE’s economic interest to 32.5%; EM markets Ibn Sina POM post-expansion Ibn Sina elastomers nylon recycled content recycled content electronics 5
Continuous innovations to expand solution set... Celanese Custom Applications LI-ION 5G UV New in 2020 ...enable growth in new markets 6
…drives growth rates far above the market Pipeline model reinforced by growth programs… R ev en ue / E ar ni ng s (T0-18 months) • Disruptive trends • Growth and profit focus • New to CE / new to customers • Technology roadmaps • Unmet customer needs • Customized material development • Curated opportunities • Differentiated customer experience PARTICIPATE ACCELERATE INCUBATE FUTURE GROWTH PROGRAMS OPPORTUNITY PIPELINE Current (T0) Note: Includes impact of COVID-19 7 MARKET BASED GROWTH
...13-17% per year through 2023 1Excludes Earnings from Affiliates 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 Adjusted EBIT (base business)1 Adjusted EBIT margin Project Pipeline & Acquisitions Growth ProgramsPre-Opportunity Pipeline >25% Softer Nilit Omni Asia growth through localization Sustainable portfolio NEXT Model and growth programs lift EM earnings... ~$300M - 500M 8 ~$450M - 700M
Leveraging years of pipeline data to make model more efficient and predictive Opportunity model continues to be foundational Customer Engagement Model Generating Projects Daily Projects to be Implemented and Extended at Customers Projects Aggregated, Prioritized & Executed Projects We Can Win Expert Committee Evalution Fast Fail Global Solution Set and Skill Domains 9
…and remained strong through market disruption Model evolves to support continued innovation... 35% win rate 10% CAGR Implement New Model Debottleneck Model SC A LE T H E M O D E L 47% win rate 16% increase in peak net sales per projectD E LI VE R IN G G R O W TH (P ea k N et S al es )1 TARGETING in Net Sales 2015 2016 700 Run Model Hard Leverage Model Maximize the Model Enhanced Efficiency Program Evolution 2023F2020201920182017 MEMBERS year over year 10 1Peak net sales denote the projected highest net sales by opportunity
Growth programs and technology innovation make EM future ready Programs aligned with mega trends Elements of program that enable growth Connectivity Dedicated Program Teams Forward Looking Objectives Aligned Technology & Product Roadmaps Voice-of-Customer Driven Approach 5G Future Mobility Medical Sustainability 11
Opportunities in future mobility expand the scope for EM solutions Safe navigation Advanced Driver Assistance Systems Lighter and safer Electric vehicle powertrain GUR exceptionally well-positioned in lithium-ion battery separator (LiBS) market CE PEER 1 PEER 2 PEER 3 Number of opportunities with new customers Number of OEM specifications in e-powertrains Growth in pipeline net sales1 from future mobility program3.5x 3.5x 2019 - 2020 24% 2019 - 20202019 - 2020 POWER 12 1Peak net sales denote the projected highest net sales by opportunity
Focused EV program driving growth beyond industry fundamentals... ...with >10% growth in auto business from 2020-2023 RECOVERY IN AUTO BUILDS (CAGR 2020-2023F) GROWING ADDRESSABLE POLYMER CONTENT (kilos per vehicle) (2020) GROWTH IN EM ACCESSIBLE POLYMER MARKET 2020 Internal Combustion Engine Hybrid Electric Battery Electric ~50% ~40% ~0% 13 21 30 Hybrid & Electric Vehicles Internal Combustion Engine CAGR 2020-23F ~11% + = Internal Combustion Engine 2020 Hybrid & Electric Vehicles Battery Electric Vehicles CAGR 2020-23F ~10% 13Based on IHS Markit data and internal estimates
Broad medical-pharma capabilities... Therapeutic AreasCapabilities • Customized POM, GUR, PBT, LCP, EVA grades • Certified biocompatibility grades • Design assistance • Analytical testing • Moldflow® for modeling and analysis • Processing support • Regulatory support • Pharma lab feasibility services • Orthopedic implants • Inhalers and injectors • Medical bags and fluid handling • Long-acting drug delivery • Lab equipment and diagnostics • Surgical instruments Orthopedics Diabetes COPD / Asthma Women’s Health Central Nervous System Disorders E X IS TI N G E M E R G IN G Ophthalmology Portfolio Customer Partnerships Segments ...enable a range of therapeutic solutions Anti-virals (e.g., HIV) Oncology 14
VitalDose® success in drug delivery systems... Industry Focus Improved Efficacy Patient-centered Treatments Fewer Interventions Value-based Healthcare Controlled Release Dynamics D yn am ic D ru g C on ce nt ra ti on Maximum Effective Concentration Minimum Effective Concentration VitalDose® Controlled Release Solution Conventional Formulation ...creating new opportunities for future growth Celanese SolutionControlled Release Excipient ® Time Platform Technology Therapeutic Areas • Drug-eluting implants • Intravaginal rings • Ophthalmic devices • Transdermal patches • Oncology • Anti-virals • Central nervous system disorders • Women’s health • Ophthalmology 15
Connectivity
Multiple mega trends are enabled by 5G... ...driving demand for high-value, tailored solutions …are creating new design requirements Improved reliability Enable smaller and higher performance antenna Broad bandwidth Part consolidation Weight reduction Improved signal integrity EMI shielding Smart City Mobile Devices ManufacturingAutomotive Telecommunication Base Station CONNECTED COMMUNITY: 5G & BEYOND 5G Advancements in ‘smart’ applications... 17
Customizing LCP to meet unique design requirements… Celanese 5G Technology Roadmap D ie le ct ri c C on st an t, D k Dissipation Factor, Df Commercial LCP & PPS ~7 ~ Dk:<3 Dk:<20 Ultra Low Df Zenite® LCP Low Dk Zenite® LCP/ Fortron® PPS High Dk Zenite® LCP Pipeline Growth1 2018 2019 2020 ...across multiple applications to drive innovation 5G Development 2018-20 2x GROWTH 18 1Peak net sales denote the projected highest net sales by opportunity
…to meet exponential global demand expansion Growing portfolio of sustainable offerings… SEGMENTS CURRENT END MARKETS Pipeline Growth1APPROACH CELANESE SOLUTION NEW END MARKETS Highly specified performance polymer Standard polymer Single-use plastics Reduced CO2 footprint Recycled content Biodegradable 2018 2019 2020 Bio-based raw materials • Eco-B POM • Clarifoil® • BlueRidgeTM • China LCP • Ecomid® Nylon • Celanex® PBT • Polifor® PP • Amorphous • Clarifoil® • BlueRidgeTM NEW NEW NEW NEW 2018-20 4x GROWTH 19 1Peak net sales denote the projected highest net sales by opportunity
...to support innovation and deliver out-sized growth Investing in Asia localization... Asia Sales Volume 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 Local Development Local Supply Winning with Local Innovators Commercial Excellence 2012- 2020 18% CAGR 2010-20 Production output In capital expenditures over the last 10 years Number of employees in region to support growth6x ~$100M 2010 - 2020 2012 - 20202010 - 2020 2x 20
>25% Adjusted EBIT (in millions) $403 ~$550 $700-750 2020 ~10% 2021-2023 13-17% 2021-2023 Engineered Materials financial outlook Sustainable Portfolio >30% 2023 19% Adjusted EBIT margin 1 2 3 4 Enhanced Pipeline Model Growth Programs Asia Localization 21
Acetate Tow Lori Ryerkerk
2 Celanese Acetate Enterprise Sustainably Forested Trees Renewable Non-food sources High Purity Cellulose + Acetic Acid Sustainable raw materials Acetate Flake Bio-based Sustainable Environmentally friendly Vinegar and Glucose Consumed by microorganisms Acetate Derivatives Acetate Tow Biodegradable Compostable
A central link in our businesses 3 Acetyl Chain Acetate Tow Engineered Materials Acetic Acid Acetate Flake Consumer of upstream products Supplier of sustainable materials Acetate Tow
Acetate Tow financial outlook STABLE INDUSTRY DYNAMICS ADJUSTED EBIT MARGIN ~45% 2023 OPERATING EBITDA MARGIN ~50% 2023 DIVIDENDS FROM AFFILIATES ~55% $249 ~$245 ~$245 2020 2021F Tow Demand Decline Affiliate Dividends Productivity 2023F 4 Adjusted EBIT (in millions) of Total Adjusted EBIT 2023 1 2 3 4 Predictable Tow Market Outlook Growing China Affiliate Dividends High Levels of Productivity Alternative Uses for Acetate Flake
Acetate Tow Appendix
Gradual, secular decline in tow demand Limited impact on tow demand from COVID-19 pandemic Stable inventory and regional trade dynamics G lo ba l C ig ar et te s (t ri ll io ns ) China Rest of World 2020 – 2023E CAGR decline of 1% 2013 2014 2015 2016 2023F2022F2021F2020201920182017 Predictable and stable market outlook 1Euromonitor International, Retail + Illicit Manageable future demand deterioration Global Cigarette Demand1 2
Estimated Global Tow Capacity (~800 kt) To w V ol um e (k t) 2013 2014 2015 2016 2023F2022F2021F2020201920182017 97% 91% 85% 87% 88% 89% 92% 92% Excess Capacity Utilization Utilization could improve further as producers continue to address cost positions Celanese Eastman Daicel Blackstone Jinan/Hubei Nantong Zhuhai Other China captive Kunming Global Tow Utilization Stabilizing industry dynamics 3 Rest of world China Based on internal estimates
Flake expansion and potential future incremental expansions Cost reductions in raw materials such as pulp and acid Growing China dividends JV dividends overview Efficiency improvements at our China JVs Increased tow sales in China Development of new flake end uses Share of China capacity Other 2013 2014 2015 2016 2022F2021F202020192018201720122006 2007 2008 2010 20112009 Celanese JV Daicel JV Eastman JV Largest China position with >70% of capacity Dividend growth drivers 4Based on internal estimates
Maintaining high level of productivity Proven productivity track record that more than offset inflation in last five years Productivity Initiatives 2015 Pulp sourcing optionality 2023F2022F2021F 7% 6% 5% 3% 4% 8% 2016 2019-2020 2020 2021-2023 • Energy reduction • Manufacturing improvements • Raw material optimization • Digitalization Capacity reduction at Lanaken Ocotlán closure Combined heat power plant at Lanaken 2015 2016 2020201920182017 Productivity Savings Percentage of Net Sales Productivity 5
Sustainability Opportunities Regional Growth Opportunities Driving value by capturing market opportunities Product Growth Opportunities OPPORTUNITY: Growth in alternatives to traditional cigarettes CE RESPONSE: Capturing market share in Heated-Tobacco Products (HTP) OPPORTUNITY: Shift in regional demand CE RESPONSE: Leading position in China and in growing markets such as Indonesia and the Middle East OPPORTUNITY: Demand for sustainable products CE RESPONSE: Designing enhanced, eco-friendly products such as low-carbon tow 2016 2022F2021F2020201920182017 150 Billion Sticks1 1Based on internal estimates Pockets of opportunity to help offset declining tow demand 6
Sustainability Lori Ryerkerk
qualitypeople safety communitycustomers shareholders SUSTAINABILITY Human Capital Optimization Right To Compete Risk Mitigation Demand Growth Central to Our Business Aligned with Our Values 2 Accelerating safe and sustainable solutions through chemistry
Our approach to sustainability GOVERNANCE: NAVIGATING A SUSTAINABLE FUTURE Three sustainability pillars under a shared governance framework Waste Water Energy Air Climate ENVIRONMENTAL Human Capital Workforce Health and Safety Process Safety and Emergency Preparedness Community Relations PRESERVING THE ENVIRONMENT SOCIETAL Chemical Safety Supply Chain Management Circular Economy COMMERCIAL INVESTING IN OUR PEOPLE AND COMMUNITIES ADVANCING SAFE AND SUSTAINABLE CUSTOMER SOLUTIONS 3
Governance: navigating a sustainable future 1 CMD - Compensation and Management Development Committee 2 NCG - Nominating and Corporate Governance Committee 3 EHSQPP - Environmental, Health, Safety, Quality and Public Policy Committee 4 UNSDG - UN Sustainability Development Goals ESG Council’s Progress: Formed ESG Council Completed ESG priority assessment Committed to adopt SASB Chemical Industry standards Launched enhanced sustainability website and proxy disclosures Formed 10 ESG expert committees to develop KPIs, baselines, and targets Developing 2020 Sustainability Report and website aligned to SASB and UNSDGs4 Commitment formalized through an ESG Council with Board oversight Board of Directors Audit Committee CMD Committee1 NCG Committee2 EHSQPP Committee3 ESG Council: business and functional experts Executive Management Our sustainable future starts with leadership Q4 2019 Q1 2020 Q2 2020 Q3 2020 Q1 2021 Q3 2019 4
Preserving the environment Strategic steps aimed to reduce our operational impact 2 From a 2021 baseline 34% reduction in solid waste intensity 2013-20191 ~160,000 MMBtu per year heat recovery and reuse from hazardous waste incinerator project 15% reduction in total waste by 20302 Committed to Operation Clean Sweep pledge for European and U.S. facilities 10% reduction in water consumption intensity by 20302 237 energy projects delivered ~$25 million in savings from 2019-2020 ~3,100 mt reduction of CO2 annually at Lanaken site from new combined heat power unit 10% reduction in total net energy intensity by 20302 37% VOC3 intensity reduction from 2013-20191 30% GHG4 intensity reduction from 2013-20191 AirEnergyWaterWaste 4 GHG - Greenhouse Gas 15% 10% 10% 30% Capturing Hazardous Air Pollutants (HAPS) in 2020 for future disclosure and target 3 VOC - Volatile Organic Compounds1 Based on internal estimates 5
Addressing climate change Adopted climate policy in 2020 and committed to establishing robust climate program 1 ~65% of the site’s daytime electricity usage during summer months 2To come online in mid-2021 Increase energy efficiency and improve reliability Recover and reuse waste heat Increase use of renewable energy and sustainable raw materials Investing in projects to: Green Initiatives at Clear Lake, Texas Facility Renewable Energy Supply Methanol Production from Recycled CO2 By-product CO2 as alternative feedstock for methanol production4 to be used in a range of end-products. 142,759 66,700MWh mt CO2 OF RENEWABLE ELECTRICITY PURCHASED DISPLACING A TOTAL OF EQUIVALENT TO taking more than cars off the road per year3 14,500 Signed a renewable energy contract to supply ~33% of the annual electricity consumption at the site.1,2 3 Carbon abatement for one year estimates using ERCOT eGRID scalers 4 Through the Fairway Joint Venture anticipated to begin mid-2023 180,000 mt CO2 DISPLACING A TOTAL OF EQUIVALENT TO taking more than cars off the road per year 39,000 6
Committed to our people and communities Driving greater engagement within Celanese and our communities Providing a diverse, equitable and inclusive culture - 50% women on Board of Directors - 28% women in management - 29% people of color in U.S. management roles Tools and resources to support employee development, career growth and wellness needs ~75% reduction in total process safety incidents 2013-2020 ~50 U.S. companies have adopted CE’s “Walk the Line” program focused on operational discipline Performed severe weather assessments for 8 CE high and medium risk facilities in 2020 $1.4 million donated to ~900 non-profit organizations in 2020 $4.4 million donated to ~1,500 non-profit organizations in 2019 900,000+ volunteer hours since 2016 ~50% reduction in total recordable incidents from 2014-2020 21 of 35 sites with no recordable injuries in 2019 Human Capital Workforce Health & Safety Community Relations Process Safety & Emergency Preparedness 7
Driving Diversity, Equity & Inclusion (DE&I)... ...for a culture of inclusion, innovation and growth 18 cross-functional employees representing 11 countries Senior leadership chair Oversight by the Board of Directors Employee Resource Groups (ERGs) to inspire, develop and increase the visibility of under-represented employee groups Engagement with key industry and academic organizations to recruit diverse talent Initiatives to support under-represented groups pursuing STEM1 degrees Global cultural awareness and heritage celebrations Supplier diversity program Global DE&I Council as our advisory committee Employee Interest Groups (EIGs) to connect employees with common interests and causes - - - 8 ERGs | 39 Chapters Leadership Employee Engagement Outreach 1 STEM - Science, Technology, Engineering, Mathematics 8
Advancing safe and sustainable customer solutions Helping our customers realize the sustainability goals of their end use products Publish product profiles prioritized by risk/volume Establish customer chemical safety education program Align with ACC’s1 product safety innovation program Sourcing of renewable energy and renewable or bio-based raw materials Improved management of supplier, vendor and contractor risk profiles ~$150 million economic benefit through Celanese purchases from small businesses2 Chemistry of platform well suited for long-term transition to more renewable feedstocks Heavy exposure to highly engineered, durable applications Focus on customer solutions that improve resource efficiency and product life Chemical Safety Sustainable SolutionsSupply Chain Management 1 ACC - American Chemistry Council 2 Minority, women and veteran-owned businesses based upon input-output analysis model 9
Enabling sustainable solutions 2020 Net Sales: $5.7B Sustainable solutions and products Significant contributor to our future net sales growth Redispersible powders reduce required tile adhesive thickness, lowering the carbon footprint by up to 50% Clarifoil® and BlueRidgeTM product offerings that are bio-based materials EM lightweighting solutions improve fuel economy by offering up to 30% mass savings vs. traditional part materials Sustainable Solutions and Products 10Based on internal estimates
On our sustainability horizon Launching the 2020 Sustainability Report and website in mid-2021 Voluntary sustainability reporting to ACC Publishing human capital metrics for increased transparency Integrating software to capture environmental SASB metrics Increasing transparency and reporting of our climate initiatives on carbon impact Leadership through consistent improvement in transparency 11 Expanding the product portfolio of sustainable solutions Setting targets for environmental goals
Acetate Tow Lori Ryerkerk Financial Excellence Scott Richardson
Disciplined focus to drive shareholder value 2 1 2 LEVERAGE OUR BUSINESSES TO DRIVE STRONG CASH GENERATION AND USE THAT CASH FOR SHAREHOLDER VALUE ACCRETION 3 INVEST TIME AND EFFORT TO EVOLVE OUR LEADING BUSINESS FRANCHISES FOCUS ON DELIVERING DOUBLE-DIGIT PER YEAR ADJUSTED EARNINGS PER SHARE GROWTH
Leading positions and business model evolution have driven performance uplift Sustained track record of earnings growth $962 $1,056 $1,268 $6.02 $1,236 $1,852 $11.00-11.50 $7.64$7.51 $11.00 $6.61 $5.67 $4.50 $4.07 $1,131 $1,476 $1,356 $1,278 $9.53 Adjusted EBIT (in millions) Adjusted Earnings Per Share 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021F 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021F 3
Consistent performance translates to shareholder value Compelling relative performance and valuation continue to drive superior returns Total Shareholder Return (February 28, 2018 – February 28, 2021) Free Cash Flow Yield (Avg. 2018 – 2020) Return on Invested Capital (Avg. 2018 – 2020) Shareholder Yield (Avg. 2018 – 2020) 47%CE 22%29%DJUSCHProxy Peers 20%CE 11%12%DJUSCHProxy Peers 8%CE 6%6%DJUSCHProxy Peers 8%CE 4%5%DJUSCHProxy Peers 4Based on FactSet and internal estimates
Two-thirds of historical shareholder value generated by controllable actions Reliably strong total shareholder returns Driven in an average year over this period by… ...positive TSR in years with average annual TSR1 of Over the last decade, CE has delivered… Multiple Expansion Earnings Growth Share Repurchases Dividends 9 15% 1Arithmetic average of TSR across each calendar year 2011 to 2020 10out of 5Based on FactSet and internal estimates
Foundational level of returns from dividends and share repurchases Dividends and Share Repurchases $65 $88 $247 $394 $594 $701 $741 $1,097 $1,300 $943 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 >$6 billion returned over the last decade and growing shareholder yield 0.6% 1.3% 3.2% 4.3% 6.2% 7.0% 5.6% 7.7% 9.5% 7.7% Repurchases Dividends Shareholder Yield 6Based on FactSet (in millions) 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Complementary pillars focus the organization on controllable actions Key pillars in place to lift earnings profile Pipeline model evolution Scaling our models Expanded optionality Productivity-based investments Incremental, capital-efficient expansions Production & supply chain optimization Product & technology enhancement Supportive of business models Feeding productivity pipeline High-Return M&A Organic Investment 2012 2013 2014 2015 2016 2017 2018 2019 2020 Adjusted EBIT (in millions) Raw material & energy efficiency Scaling our production Process & system automation Productivity Business Model Enhancement 2011 7 $950-1,300 $1,100-1,400 $1,300-1,600 1
Earnings growth begins with productivity culture 2015 2016 2017 2018 2019 2020 Historical Productivity (in millions) $235 $165 $145 $125 $168 $214 ~$150 M Average 2020 Productivity Business Enterprise Manufacturing Procurement Elevated and highly sustainable productivity in 2020 8
Productivity remains core component of organic investment Clear Lake Acetic Acid Expansion European Compounding Center of Excellence End to End Supply Chain Transformation (Wave 1) Acetyl Chain • Low-cost natural gas feedstock • Raw material & catalyst usage gains • Fixed cost scale ROCE 25%+ Business Capital Cost & Completion Productivity Engineered Materials <$20M • Consolidate European footprint • Improve compounding utilization • Leverage existing infrastructure Simple Payback All • Supply chain optimization tools • Process optimization • Analytics platforms 2021 Savings Three examples of how productivity contributes to top tier capital returns 1 2 <$350M <$25M 3 2.5 years 2023 2022 2021 ~$20M 9Based on internal estimates
Annual productivity is comprised of hundreds of individual projects Example of end to end supply chain transformation Multiple Waves Three BenefitsHundreds of Drivers11 Project Workstreams (Wave 1) Wave 1 Wave 2 Advanced Statistical Forecasting Supply Network Planning Production Schedule Optimization End-to-End Cost-to-Serve Sampling Execution Distribution Network Optimization Customer Experience Solutions New supply chain technology tools10 Corporate functions optimized 10 Hours of work take out>20k RPA’s1 (“Bots”)20 Productivity Savings Customer Satisfaction Employee Satisfaction 1RPA - Robotic Process Automation 10
Revitalizing a deep organic investment pipeline to drive future returns Organic investments represent highest return opportunities 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021F 2022F 2023F 5% 6% 10% 9% 5%5% 5% 6%6% 2020 CAPEXHistorical CAPEX Cost Reduction Maintenance of Business EHS1 Revenue Generation % of Net Sales 11 Total 1EHS - Environmental, Health and Safety
Highly disciplined capital allocation strategy ROIC (Avg. 2018-2020) CE Peer 1 Peer 2 Peer 3 Peer 4 Peer 5 Peer 6 Peer 7 Peer 8 Peer 9 Peer 10 Peer 11 Peer 12 Peer 13 Peer 14 Peer 15 Peer 16 19.6% Unwavering discipline drives top tier return on capital 12Based on FactSet and internal estimates
Business plans to yield high-quality earnings ENGINEERED MATERIALS • Project pipeline and incremental investments • >85% adjusted EBIT from base business • Upside from M&A potential • Leading network optionality and incremental expansion • Earnings profile on normalized industry dynamics • Upside from M&A potential and industry dynamics • Stabilized industry dynamics • Secular demand declines offset by productivity • >50% from growing Chinese affiliate dividends ACETATE TOW ACETYL CHAIN $700- ~$245 Elevating the sustainable earnings profile of our businesses million $1.7-1.8 billion1 EBIT Adjusted 2023 13 1Includes Other Activities 750 $900-1,000 million million
Excess cash generation between 2021 and 2023 for further deployment Cumulative Operating Cash Flow (2021 - 2023) (in billions) Uses of Operating Cash Flow (2021 - 2023) (in billions) 2021F 2022F 2023F >$1.5-2.5 excess cash generation for share repurchases and M&A CAPEX ~$1.5 DIVIDENDS ~$1.0 Business plans yield powerful cash generation ~$4-5 14Based on internal estimates
Flexible, diversified balance sheet enables growth strategy Ability to access multiple debt markets quickly and efficiently $0 $1000 2021 2022 2023 20241 2025 2026 2027 € Bond $ Bond 1Prepayable $1.25 billion revolver matures in 2024. Zero balance as of December 31, 2020. Debt / EBITDA 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021F 1.6 2.2 2.5 2.3 1.7 2.0 1.9 2.2 1.6 2.2 2.5 1.9 15 Debt Maturity Profile (in millions)
Additional firepower on the balance sheet Central Nervous System DisordersOphthalmology Current Excess Cash Levels Cash Generation (2021-2023) Balance Sheet Capacity (through 2023) Excess Cash Balance1 Operating Cash Flow Dividends Capital Expenditures Additional Debt Capacity2 Firepower available to drive growth including M&A and share repurchases Up to $6B available through 2023 for oppor unistic deployment $1.2B $4.0-5.0B $1.0B $1.5B $2.0B $6.0B 1As of December 31, 2020 2Estimated minimum additional debt capacity by 2023 while maintaining Investment Grade credit rating 16 Up to
Sustaining double-digit growth in adjusted earnings per share… Winning in key end markets Transforming our productivity Driving greater sustainability Enhancing our capital deployment $7.64 $13.00-14.00 2020 2021F Engineered Materials Acetyl Chain Acetate Tow 2023F Double- digit CAGR Adjusted Earnings Per Share …on business earnings growth, cash conversion and capital deployment strategy 17 3 2 1 4 $11.00-11.50
Glossary 1Or operating profit if adjusted earnings metric not provided 2Or GAAP income taxes if adjusted income taxes not provided 20 For Celanese Non-GAAP measures, please refer to the Non-US GAAP Financial Measures and Supplemental Information documents under Financial Information/Non-GAAP Financial Measures on our investor relations website, investors.celanese.com • Average Market Cap is the average of quarterly beginning and ending market caps during each measurement period. For instance, 2020 average market cap is the average of market caps of the beginning of Q1, and the ending of Q1, Q2, Q3, and Q4 of 2020. • Dividend Yield is defined as Common Stock Cash Dividends Paid divided by Average Market Cap. (6) • Free Cash Flow for proxy peers and DJUSCH index is defined as Cash Flow from Operations less Capital Expenditures; Free Cash Flow for Celanese is per Celanese non-GAAP disclosure. • Free Cash Flow Yield is defined as Free Cash Flow divided by Average Market Cap. (4) • Debt to EBITDA Ratio is defined as Total Debt divided by Operating EBITDA. (15) • Proxy Peers include ALB, APD, ASH, AVNT, AXTA, CC, CF, ECL, EMN, FMC, HUN, IFF, LYB, PPG, RPM, SHW. (4, 12) • Repurchase Yield is defined as Share Repurchases divided by Average Market Cap. (6) • ROIC for proxy peers is defined as adjusted earnings1 tax effected, divided by the average Invested Capital at the beginning and ending of each measurement period. ROIC = adjusted EBIT less adjusted income taxes2) / (average Total Debt + average Stockholders’ Equity). (4, 12); ROIC for Celanese is per Celanese non-GAAP disclosure. • Shareholder Yield is defined as the sum of Dividend Yield and Repurchase Yield. (4, 6)
Wrap Up Lori Ryerkerk
2 Keep in mind… 1 OUR 2023 OUTLOOK IS BASED ON CONTROLLABLE ACTIONS 2 THERE ARE SIGNIFICANT VALUE OPPORTUNITIES BEYOND WHATIS INCLUDED IN OUR 2023 OUTLOOK 3 WE ARE TAKING ACTIONS TODAY TO DELIVER INCREMENTALGROWTH BEYOND 2023
...driven by controllable actions 2012 2013 2014 2015 2016 2017 2018 2019 2020 Average market capitalization (in billions) Share price 20211 $6.6 $7.9 $9.1 $15.2 $12.1 $9.7 $9.9 $13.2 $14.5 $13.7 3 History of sustained growth... Based on FactSet 12021 share price and average market capitalization from January 1, 2021-February 28, 2021
Additional growth opportunities Broad replacement of single-use plastics with sustainable alternatives Acceleration of US, EU, or China infrastructure development Material acetyls curtailment or rationalization activity in China Tow industry rationalization or consolidation Actionability of industry M&A, particularly transformational Accelerated global transition to electric and hybrid vehicles Uniquely positioned to drive these opportunities for further earnings growth 4
Real value generated from our business portfolio Any portfolio change must be part of an opportunity for greater value Diversification Cost Efficiency Natural Hedges Capital Allocation End market diversification Business cycles Oil volatility Complementary capital needs Raw material swings Currency Complementary cash generation Shared primary raw materials Shared corporate functions Cross-business product flows #1 Auto #2 Electrical & Electronics #3 Industrial #1 Coatings #2 Adhesives #3 Packaging #1 Filtration ~$50M annually ENGINEERED MATERIALS ACETYL CHAIN ACETATE TOW 5 Talent and business model overlap
Disciplined M&A pipeline criteria Industry Consistently applying criteria to evaluate pipeline of high-return M&A opportunities Financial Industry leadership Competitive cost position Upstream or downstream value creation High synergy opportunities Opportunity to unlock growth Double-digit IRR Commercial Technical High customer intimacy Aligns well with commercial model Complementary (region, end market) Differentiated offering (products, capabilities, services) Differentiated technology & strong IP Application know-how Formulation expertise 6
Synergistic opportunities that leverage our commercial model, capabilities and product portfolio Broad M&A opportunity set in Engineered Materials Polymers & Materials ApplicationsRegions Capabilities Orthopedic Implants Electrical Energy Storage Renewable Energy Resorbable Pharma Excipient Biopolymers High Temperature Polymers High Performance Fibers Composite Solutions EMI Shielding Flame Retardancy Part Manufacturing Additive Manufacturing Medical Molding Electronic Chemicals Thermosets Form Factors Mexico India Southeast Asia Existing PolymersRecycling Current Core Geographies Single-Use Plastic Alternatives Aerospace Advanced Mobility 5G Core Adjacent Emerging 7
Committed to delivering outsized value creation through strong execution and M&A Significant upside with M&A 1 Excess cash generation and cash reserves following dividends and capital expenditures Market Capitalization Growth Outlook (in billions)1 2 3 Outlook assumes 100% of excess cash generation1 goes to share repurchases and M&A !"#$%&'(") *+*+ *+*, *+** *+*- Potential for $2-3B value creation2 from M&A synergies Additional value opportunity through rerating from demonstrated track record and portfolio 2015 2020 20213 2023F-2025F $10 $12 $15 Earnings Expansion $5+ $20+ approaching M&A Opportunity Up To 8 2 Range dependent on various factors including deal structure, valuation, synergy profile, etc.Based on FactSet and internal estimates 3 Average market capitalization from January 1, 2021 - February 28, 2021
Extending our strategic investment horizon Controllable actions today to deliver value beyond 2023 Adjusted Earnings Per Share 2018 2019 2020 2021F 2022F 2023F 2024F 2025F $7.64 $9.53 $11.00 $8-10 $11-14 Contributors Beyond 2023 (startup within 2023 or after) Startup 2023 2023 2023 2023 2023 Acetyl Chain Clear Lake acetic acid expansion Methanol from CO2 Nanjing VAM expansion Frankfurt emulsions expansion Nanjing emulsions expansion Engineered Materials Nanjing compounding expansion LCP China capacity EU GUR expansion 2023 2024 2024 9
How we deliver shareholder value… 3 2 1 4 5 6 10 Multiplying Our Momentum Deliver shareholder value on what we can control Partner with our customers to deliver innovative solutions Expand and flex our commercial optionality Allocate our capital with a disciplined focus on returns Foster a culture of diversity, equity and inclusion Deliver a growing portfolio of sustainable products
Exhibit 99.3A
Non-US GAAP Financial Measures and Supplemental Information
January 28, 2021
In this document, the terms the "Company," "we" and "our" refer to Celanese Corporation and its subsidiaries on a consolidated basis.
Purpose
The purpose of this document is to provide information of interest to investors, analysts and other parties including supplemental financial information and reconciliations and other information concerning our use of non-US GAAP financial measures. This document is updated quarterly.
Presentation
This document presents the Company's three business segments, Engineered Materials, Acetate Tow and Acetyl Chain.
Use of Non-US GAAP Financial Measures
From time to time, management may publicly disclose certain numerical "non-GAAP financial measures" in the course of our earnings releases, financial presentations, earnings conference calls, investor and analyst meetings and otherwise. For these purposes, the Securities and Exchange Commission ("SEC") defines a "non-GAAP financial measure" as a numerical measure of historical or future financial performance, financial position or cash flows that excludes amounts, or is subject to adjustments that effectively exclude amounts, included in the most directly comparable measure calculated and presented in accordance with US GAAP, and vice versa for measures that include amounts, or are subject to adjustments that effectively include amounts, that are excluded from the most directly comparable US GAAP measure so calculated and presented. For these purposes, "GAAP" refers to generally accepted accounting principles in the United States.
Non-GAAP financial measures disclosed by management are provided as additional information to investors, analysts and other parties because the Company believes them to be important supplemental measures for assessing our financial and operating results and as a means to evaluate our financial condition and period-to-period comparisons. These non-GAAP financial measures should be viewed as supplemental to, and should not be considered in isolation or as alternatives to, net earnings (loss), operating profit (loss), operating margin, cash flow from operating activities (together with cash flow from investing and financing activities), earnings per share or any other US GAAP financial measure. These non-GAAP financial measures should be considered within the context of our complete audited and unaudited financial results for the given period, which are available on the Financial Information/Financial Document Library page of our website, investors.celanese.com. The definition and method of calculation of the non-GAAP financial measures used herein may be different from other companies' methods for calculating measures with the same or similar titles. Investors, analysts and other parties should understand how another company calculates such non-GAAP financial measures before comparing the other company's non-GAAP financial measures to any of our own. These non-GAAP financial measures may not be indicative of the historical operating results of the Company nor are they intended to be predictive or projections of future results.
Pursuant to the requirements of SEC Regulation G, whenever we refer to a non-GAAP financial measure, we will also present in this document, in the presentation itself or on a Form 8-K in connection with the presentation on the Financial Information/Financial Document Library page of our website, investors.celanese.com, to the extent practicable, the most directly comparable financial measure calculated and presented in accordance with GAAP, along with a reconciliation of the differences between the non-GAAP financial measure we reference and such comparable GAAP financial measure.
This document includes definitions and reconciliations of non-GAAP financial measures used from time to time by the Company.
Specific Measures Used
This document provides information about the following non-GAAP measures: adjusted EBIT, adjusted EBIT margin, operating EBITDA, operating EBITDA margin, operating profit (loss) attributable to Celanese Corporation, adjusted earnings per share, net debt, free cash flow and return on invested capital (adjusted). The most directly comparable financial measure presented in accordance with US GAAP in our consolidated financial statements for adjusted EBIT and operating EBITDA is net earnings (loss) attributable to Celanese Corporation; for adjusted EBIT margin and operating EBITDA margin is operating margin; for operating profit (loss) attributable to Celanese Corporation is operating profit (loss); for adjusted earnings per share is earnings (loss) from continuing operations attributable to Celanese Corporation per common share-diluted; for net debt
1
is total debt; for free cash flow is net cash provided by (used in) operations; and for return on invested capital (adjusted) is net earnings (loss) attributable to Celanese Corporation divided by the sum of the average of beginning and end of the year short- and long-term debt and Celanese Corporation stockholders' equity.
Definitions
•Adjusted EBIT is a performance measure used by the Company and is defined by the Company as net earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income, plus interest expense, plus refinancing expense and taxes, and further adjusted for Certain Items (refer to Table 8). We believe that adjusted EBIT provides transparent and useful information to management, investors, analysts and other parties in evaluating and assessing our primary operating results from period-to-period after removing the impact of unusual, non-operational or restructuring-related activities that affect comparability. Our management recognizes that adjusted EBIT has inherent limitations because of the excluded items. Adjusted EBIT is one of the measures management uses for planning and budgeting, monitoring and evaluating financial and operating results and as a performance metric in the Company's incentive compensation plan. We do not provide reconciliations for adjusted EBIT on a forward-looking basis (including those contained in this document) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of Certain Items, such as mark-to-market pension gains and losses, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information. Adjusted EBIT margin is defined by the Company as adjusted EBIT divided by net sales. Adjusted EBIT margin has the same uses and limitations as Adjusted EBIT.
•Operating EBITDA is a performance measure used by the Company and is defined by the Company as net earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income, plus interest expense, plus refinancing expense, taxes and depreciation and amortization, and further adjusted for Certain Items, which Certain Items include accelerated depreciation and amortization expense. Operating EBITDA is equal to adjusted EBIT plus depreciation and amortization. We believe that Operating EBITDA provides transparent and useful information to investors, analysts and other parties in evaluating our operating performance relative to our peer companies. Operating EBITDA margin is defined by the Company as Operating EBITDA divided by net sales. Operating EBITDA margin has the same uses and limitations as Operating EBITDA.
•Operating profit (loss) attributable to Celanese Corporation is defined by the Company as operating profit (loss), less earnings (loss) attributable to noncontrolling interests ("NCI"). We believe that operating profit (loss) attributable to Celanese Corporation provides transparent and useful information to management, investors, analysts and other parties in evaluating our core operational performance. Operating margin attributable to Celanese Corporation is defined by the Company as operating profit (loss) attributable to Celanese Corporation divided by net sales. Operating margin attributable to Celanese Corporation has the same uses and limitations as Operating profit (loss) attributable to Celanese Corporation.
•Adjusted earnings per share is a performance measure used by the Company and is defined by the Company as earnings (loss) from continuing operations attributable to Celanese Corporation, adjusted for income tax (provision) benefit, Certain Items, and refinancing and related expenses, divided by the number of basic common shares and dilutive restricted stock units and stock options calculated using the treasury method. We believe that adjusted earnings per share provides transparent and useful information to management, investors, analysts and other parties in evaluating and assessing our primary operating results from period-to-period after removing the impact of the above stated items that affect comparability and as a performance metric in the Company's incentive compensation plan. We do not provide reconciliations for adjusted earnings per share on a forward-looking basis (including those contained in this document) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of Certain Items, such as mark-to-market pension gains and losses, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information.
Note: The income tax expense (benefit) on Certain Items ("Non-GAAP adjustments") is determined using the applicable rates in the taxing jurisdictions in which the Non-GAAP adjustments occurred and includes both current and deferred income tax expense (benefit). The income tax rate used for adjusted earnings per share approximates the midpoint in a range of forecasted tax rates for the year. This range may include certain partial or full-year forecasted tax opportunities and related costs, where applicable, and specifically excludes changes in uncertain tax positions, discrete recognition of GAAP items on a quarterly basis, other pre-tax items adjusted out of our GAAP earnings for adjusted earnings per share purposes and changes in management's assessments regarding the ability to realize deferred tax assets for GAAP. In determining the adjusted earnings per share tax rate, we reflect the impact of foreign tax credits when utilized, or expected to be utilized, absent discrete events impacting the timing of foreign tax credit utilization. We analyze this rate quarterly and adjust it if there is a material change in the range of forecasted tax rates; an updated forecast would not necessarily result in a change to our tax rate used for adjusted earnings per share. The adjusted tax rate is an estimate and may differ from the actual tax rate used for GAAP reporting in any given reporting period. Table 3a summarizes the reconciliation of our estimated GAAP effective tax rate to the adjusted tax rate. The estimated GAAP rate excludes discrete recognition of GAAP items due to our inability to forecast such items. As part of the year-end reconciliation, we will update the reconciliation of the GAAP effective tax rate to the adjusted tax rate for actual results.
2
•Free cash flow is a liquidity measure used by the Company and is defined by the Company as net cash provided by (used in) operations, less capital expenditures on property, plant and equipment, and adjusted for capital contributions from or distributions to Mitsui & Co., Ltd. ("Mitsui") related to our methanol joint venture, Fairway Methanol LLC ("Fairway"). We believe that free cash flow provides useful information to management, investors, analysts and other parties in evaluating the Company's liquidity and credit quality assessment because it provides an indication of the long-term cash generating ability of our business. Although we use free cash flow as a measure to assess the liquidity generated by our business, the use of free cash flow has important limitations, including that free cash flow does not reflect the cash requirements necessary to service our indebtedness, lease obligations, unconditional purchase obligations or pension and postretirement funding obligations.
•Net debt is defined by the Company as total debt less cash and cash equivalents. We believe that net debt provides useful information to management, investors, analysts and other parties in evaluating changes to the Company's capital structure and credit quality assessment.
•Return on invested capital (adjusted) is defined by the Company as adjusted EBIT, tax effected using the adjusted tax rate, divided by the sum of the average of beginning and end of the year short- and long-term debt and Celanese Corporation stockholders' equity. We believe that return on invested capital (adjusted) provides useful information to management, investors, analysts and other parties in order to assess our income generation from the point of view of our stockholders and creditors who provide us with capital in the form of equity and debt and whether capital invested in the Company yields competitive returns.
Supplemental Information
Supplemental Information we believe to be of interest to investors, analysts and other parties includes the following:
•Net sales for each of our business segments and the percentage increase or decrease in net sales attributable to price, volume, currency and other factors for each of our business segments.
•Cash dividends received from our equity investments.
•For those consolidated ventures in which the Company owns or is exposed to less than 100% of the economics, the outside stockholders' interests are shown as NCI. Beginning in 2014, this includes Fairway for which the Company's ownership percentage is 50%. Amounts referred to as "attributable to Celanese Corporation" are net of any applicable NCI.
Results Unaudited
The results in this document, together with the adjustments made to present the results on a comparable basis, have not been audited and are based on internal financial data furnished to management. Quarterly results should not be taken as an indication of the results of operations to be reported for any subsequent period or for the full fiscal year.
3
Table 1
Adjusted EBIT and Operating EBITDA - Reconciliation of Non-GAAP Measures - Unaudited
| 2020 | 2019 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (In $ millions) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net earnings (loss) attributable to Celanese Corporation | 1,985 | 852 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Earnings) loss from discontinued operations | 12 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest income | (6) | (6) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest expense | 109 | 115 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinancing expense | — | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Income tax provision (benefit) | 247 | 124 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Certain Items attributable to Celanese Corporation (Table 8) | (1,216) | 381 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjusted EBIT | 1,131 | 1,476 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Depreciation and amortization expense(1) | 344 | 329 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Operating EBITDA | 1,475 | 1,805 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2020 | 2019 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (In $ millions) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Engineered Materials | 5 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acetate Tow | — | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acetyl Chain | 1 | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Activities(2) | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accelerated depreciation and amortization expense | 6 | 23 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Depreciation and amortization expense(1) | 344 | 329 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total depreciation and amortization expense | 350 | 352 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
______________________________
(1)Excludes accelerated depreciation and amortization expense as detailed in the table above, which amounts are included in Certain Items above.
(2)Other Activities includes corporate Selling, general and administrative ("SG&A") expenses, the results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).
4
| Table 2 - Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating EBITDA - Non-GAAP Measures - Unaudited | | |||||||
| 2020 | 2019 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (In $ millions, except percentages) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Operating Profit (Loss) / Operating Margin | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Engineered Materials | 235 | 11.3 | % | 446 | 18.7 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acetate Tow | 118 | 22.7 | % | 52 | 8.2 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Acetyl Chain(1) | 563 | 17.9 | % | 678 | 20.0 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Activities(2) | (252) | (342) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 664 | 11.7 | % | 834 | 13.2 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Less: Net Earnings (Loss) Attributable to NCI(1) | 7 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Operating Profit (Loss) Attributable to Celanese Corporation | 657 | 11.6 | % | 828 | 13.1 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Operating Profit (Loss) / Operating Margin Attributable to Celanese Corporation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Engineered Materials | 235 | 11.3 | % | 446 | 18.7 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acetate Tow | 118 | 22.7 | % | 52 | 8.2 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Acetyl Chain(1) | 556 | 17.7 | % | 672 | 19.8 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Activities(2) | (252) | (342) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 657 | 11.6 | % | 828 | 13.1 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity Earnings and Dividend Income, Other Income (Expense) Attributable to Celanese Corporation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Engineered Materials | 115 | 168 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acetate Tow | 126 | 112 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acetyl Chain | 5 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Activities(2) | 19 | 2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 265 | 287 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-Operating Pension and Other Post-Retirement Employee Benefit (Expense) Income Attributable to Celanese Corporation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Engineered Materials | 1 | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acetate Tow | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acetyl Chain | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Activities(2) | 16 | (20) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 17 | (20) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Gain (Loss) On Sale of Investments in Affiliates | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Engineered Materials | 1,408 | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acetate Tow | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acetyl Chain | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Activities(2) | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 1,408 | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Certain Items Attributable to Celanese Corporation (Table 8) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Engineered Materials | (1,356) | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acetate Tow | 5 | 104 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acetyl Chain | 7 | 50 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Activities(2) | 128 | 220 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | (1,216) | 381 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
___________________________
(1)Net earnings (loss) attributable to NCI is included within the Acetyl Chain segment.
(2)Other Activities includes corporate SG&A expenses, the results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).
5
| Table 2 - Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating EBITDA - Non-GAAP Measures - Unaudited (cont.) | | |||||||
| 2020 | 2019 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (In $ millions, except percentages) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adjusted EBIT / Adjusted EBIT Margin | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Engineered Materials | 403 | 19.4 | % | 621 | 26.0 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acetate Tow | 249 | 48.0 | % | 268 | 42.1 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acetyl Chain | 568 | 18.0 | % | 727 | 21.4 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Activities(2) | (89) | (140) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 1,131 | 20.0 | % | 1,476 | 23.4 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Depreciation and Amortization Expense(1) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Engineered Materials | 129 | 127 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acetate Tow | 36 | 36 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acetyl Chain | 162 | 151 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Activities(2) | 17 | 15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 344 | 329 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Operating EBITDA / Operating EBITDA Margin | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Engineered Materials | 532 | 25.6 | % | 748 | 31.3 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acetate Tow | 285 | 54.9 | % | 304 | 47.8 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acetyl Chain | 730 | 23.2 | % | 878 | 25.9 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Activities(2) | (72) | (125) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 1,475 | 26.1 | % | 1,805 | 28.7 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
___________________________
(1)Excludes accelerated depreciation and amortization expense, which amounts are included in Certain Items above. See Table 1 for details.
(2)Other Activities includes corporate SG&A expenses, the results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).
6
Table 3
Adjusted Earnings (Loss) per Share - Reconciliation of a Non-GAAP Measure - Unaudited
| 2020 | 2019 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| per share | per share | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (In $ millions, except per share data) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings (loss) from continuing operations attributable to Celanese Corporation | 1,997 | 16.85 | 858 | 6.89 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income tax provision (benefit) | 247 | 124 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings (loss) from continuing operations before tax | 2,244 | 982 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Certain Items attributable to Celanese Corporation (Table 8) | (1,216) | 381 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refinancing and related expenses | — | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adjusted earnings (loss) from continuing operations before tax | 1,028 | 1,367 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income tax (provision) benefit on adjusted earnings(1) | (123) | (178) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adjusted earnings (loss) from continuing operations(2) | 905 | 7.64 | 1,189 | 9.53 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Diluted shares (in millions)(3) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Weighted average shares outstanding | 117.8 | 123.9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Incremental shares attributable to equity awards | 0.7 | 0.8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total diluted shares | 118.5 | 124.7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
______________________________
(1)Calculated using adjusted effective tax rates (Table 3a) as follows:
| 2020 | 2019 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (In percentages) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adjusted effective tax rate | 12 | 13 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(2)Excludes the immediate recognition of actuarial gains and losses and the impact of actual vs. expected plan asset returns.
| Actual Plan Asset Returns | Expected Plan Asset Returns | |||||||||||||
| (In percentages) | ||||||||||||||
| Q4 '20 & 2020 | 12.4 | 6.5 | ||||||||||||
| Q4 '19 & 2019 | 16.7 | 6.5 | ||||||||||||
(3)Potentially dilutive shares are included in the adjusted earnings per share calculation when adjusted earnings are positive.
7
Table 3a
Adjusted Tax Rate - Reconciliation of a Non-GAAP Measure - Unaudited
| Actual | |||||||||||
| 2020 | 2019 | ||||||||||
| (In percentages) | |||||||||||
| US GAAP annual effective tax rate | 11 | 13 | |||||||||
Discrete quarterly recognition of GAAP items(1) | 12 | — | |||||||||
Tax impact of other charges and adjustments(2) | (9) | — | |||||||||
| Utilization of foreign tax credits | (3) | (3) | |||||||||
Changes in valuation allowances, excluding impact of other charges and adjustments(3) | — | 3 | |||||||||
Other(4) | 1 | — | |||||||||
| Adjusted tax rate | 12 | 13 | |||||||||
______________________________
Note: As part of the year-end reconciliation, we updated the reconciliation of the GAAP effective tax rate for actual results.
(1)Such as changes in tax laws (including US tax reform), deferred taxes on outside basis differences, changes in uncertain tax positions and prior year audit adjustments.
(2)Reflects the tax impact on pre-tax adjustments presented in Certain Items (Table 8), which are excluded from pre-tax income for adjusted earnings per share purposes.
(3)Reflects changes in valuation allowances related to changes in judgment regarding the realizability of deferred tax assets or current year operations, excluding other charges and adjustments.
(4)Tax impacts related to full-year forecasted tax opportunities and related costs.
8
Table 4
Net Sales by Segment - Unaudited
| 2020 | 2019 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (In $ millions) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Engineered Materials | 2,081 | 2,386 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acetate Tow | 519 | 636 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acetyl Chain | 3,147 | 3,392 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Intersegment eliminations(1) | (92) | (117) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net sales | 5,655 | 6,297 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
___________________________
(1)Includes intersegment sales primarily related to the Acetyl Chain.
9
Table 4a
Factors Affecting Segment Net Sales Sequentially - Unaudited
Three Months Ended December 31, 2020 Compared to Three Months Ended September 30, 2020
| Volume | Price | Currency | Other | Total | ||||||||||||||||||||||||||||
| (In percentages) | ||||||||||||||||||||||||||||||||
| Engineered Materials | 7 | — | 2 | — | 9 | |||||||||||||||||||||||||||
| Acetate Tow | 4 | (1) | — | — | 3 | |||||||||||||||||||||||||||
| Acetyl Chain | 6 | 10 | 1 | — | 17 | |||||||||||||||||||||||||||
| Total Company | 7 | 5 | 1 | — | 13 | |||||||||||||||||||||||||||
Three Months Ended September 30, 2020 Compared to Three Months Ended June 30, 2020
| Volume | Price | Currency | Other | Total | ||||||||||||||||||||||||||||
| (In percentages) | ||||||||||||||||||||||||||||||||
| Engineered Materials | 27 | (6) | 4 | — | 25 | |||||||||||||||||||||||||||
| Acetate Tow | 1 | 1 | 1 | — | 3 | |||||||||||||||||||||||||||
| Acetyl Chain | 18 | (2) | 1 | — | 17 | |||||||||||||||||||||||||||
| Total Company | 20 | (3) | 2 | (1) | 18 | |||||||||||||||||||||||||||
Three Months Ended June 30, 2020 Compared to Three Months Ended March 31, 2020
| Volume | Price | Currency | Other | Total | ||||||||||||||||||||||||||||
| (In percentages) | ||||||||||||||||||||||||||||||||
| Engineered Materials | (25) | — | — | — | (25) | |||||||||||||||||||||||||||
| Acetate Tow | (3) | 1 | — | — | (2) | |||||||||||||||||||||||||||
| Acetyl Chain | (6) | (11) | — | — | (17) | (1) | ||||||||||||||||||||||||||
| Total Company | (13) | (6) | — | 1 | (18) | |||||||||||||||||||||||||||
Three Months March 31, 2020 Compared to Three Months Ended December 31, 2019
| Volume | Price | Currency | Other | Total | ||||||||||||||||||||||||||||
| (In percentages) | ||||||||||||||||||||||||||||||||
| Engineered Materials | 4 | — | — | — | 4 | |||||||||||||||||||||||||||
| Acetate Tow | (9) | (4) | — | — | (13) | |||||||||||||||||||||||||||
| Acetyl Chain | 5 | (1) | — | — | 4 | |||||||||||||||||||||||||||
| Total Company | 3 | (1) | — | — | 2 | |||||||||||||||||||||||||||
Three Months Ended December 31, 2019 Compared to Three Months Ended September 30, 2019
| Volume | Price | Currency | Other | Total | ||||||||||||||||||||||||||||
| (In percentages) | ||||||||||||||||||||||||||||||||
| Engineered Materials | (9) | — | — | — | (9) | |||||||||||||||||||||||||||
| Acetate Tow | (6) | — | — | — | (6) | |||||||||||||||||||||||||||
| Acetyl Chain | (11) | — | — | — | (11) | |||||||||||||||||||||||||||
| Total Company | (10) | — | — | — | (10) | |||||||||||||||||||||||||||
Three Months Ended September 30, 2019 Compared to Three Months Ended June 30, 2019
| Volume | Price | Currency | Other | Total | ||||||||||||||||||||||||||||
| (In percentages) | ||||||||||||||||||||||||||||||||
| Engineered Materials | 2 | (2) | (1) | — | (1) | |||||||||||||||||||||||||||
| Acetate Tow | (2) | (1) | — | — | (3) | |||||||||||||||||||||||||||
| Acetyl Chain | 1 | — | (1) | — | — | |||||||||||||||||||||||||||
| Total Company | 2 | (1) | (1) | — | — | |||||||||||||||||||||||||||
Three Months Ended June 30, 2019 Compared to Three Months Ended March 31, 2019
| Volume | Price | Currency | Other | Total | ||||||||||||||||||||||||||||
| (In percentages) | ||||||||||||||||||||||||||||||||
| Engineered Materials | (7) | (3) | (1) | — | (11) | |||||||||||||||||||||||||||
| Acetate Tow | (1) | — | — | — | (1) | |||||||||||||||||||||||||||
| Acetyl Chain | 2 | (4) | (1) | — | (3) | |||||||||||||||||||||||||||
| Total Company | (2) | (3) | (1) | — | (6) | |||||||||||||||||||||||||||
Three Months Ended March 31, 2019 Compared to Three Months Ended December 31, 2018
| Volume | Price | Currency | Other | Total | ||||||||||||||||||||||||||||
| (In percentages) | ||||||||||||||||||||||||||||||||
| Engineered Materials | 5 | 2 | — | — | 7 | (2) | ||||||||||||||||||||||||||
| Acetate Tow | 1 | 2 | — | — | 3 | |||||||||||||||||||||||||||
| Acetyl Chain | 5 | (10) | — | — | (5) | |||||||||||||||||||||||||||
| Total Company | 5 | (5) | — | — | — | |||||||||||||||||||||||||||
________________________
(1)2020 includes the effect of the acquisition of the Elotex® brand.
(2)2019 includes the effect of the acquisition of Next Polymers Ltd.
10
Table 4b
Factors Affecting Segment Net Sales Year Over Year - Unaudited
Three Months Ended December 31, 2020 Compared to Three Months Ended December 31, 2019
| Volume | Price | Currency | Other | Total | |||||||||||||||||||||||||
| (In percentages) | |||||||||||||||||||||||||||||
| Engineered Materials | 6 | (4) | 4 | — | 6 | ||||||||||||||||||||||||
| Acetate Tow | (7) | (3) | 1 | — | (9) | ||||||||||||||||||||||||
| Acetyl Chain | 19 | (3) | 2 | — | 18 | ||||||||||||||||||||||||
| Total Company | 12 | (4) | 3 | — | 11 | ||||||||||||||||||||||||
Three Months Ended September 30, 2020 Compared to Three Months Ended September 30, 2019
| Volume | Price | Currency | Other | Total | |||||||||||||||||||||||||
| (In percentages) | |||||||||||||||||||||||||||||
| Engineered Materials | (10) | (3) | 2 | — | (11) | ||||||||||||||||||||||||
| Acetate Tow | (15) | (3) | — | — | (18) | ||||||||||||||||||||||||
| Acetyl Chain | (1) | (11) | 1 | — | (11) | ||||||||||||||||||||||||
| Total Company | (6) | (7) | 1 | 1 | (11) | ||||||||||||||||||||||||
Three Months Ended June 30, 2020 Compared to Three Months Ended June 30, 2019
| Volume | Price | Currency | Other | Total | |||||||||||||||||||||||||
| (In percentages) | |||||||||||||||||||||||||||||
| Engineered Materials | (27) | (1) | (1) | — | (29) | ||||||||||||||||||||||||
| Acetate Tow | (18) | (5) | — | — | (23) | ||||||||||||||||||||||||
| Acetyl Chain | (14) | (8) | (1) | — | (23) | ||||||||||||||||||||||||
| Total Company | (20) | (5) | (1) | 1 | (25) | ||||||||||||||||||||||||
Three Months Ended March 31, 2020 Compared to Three Months Ended March 31, 2019
| Volume | Price | Currency | Other | Total | |||||||||||||||||||||||||
| (In percentages) | |||||||||||||||||||||||||||||
| Engineered Materials | (9) | (5) | (1) | — | (15) | ||||||||||||||||||||||||
| Acetate Tow | (17) | (5) | — | — | (22) | ||||||||||||||||||||||||
| Acetyl Chain | (3) | (7) | (1) | 1 | (10) | ||||||||||||||||||||||||
| Total Company | (7) | (6) | (1) | 1 | (13) | ||||||||||||||||||||||||
Three Months Ended December 31, 2019 Compared to Three Months Ended December 31, 2018
| Volume | Price | Currency | Other | Total | |||||||||||||||||||||||||
| (In percentages) | |||||||||||||||||||||||||||||
| Engineered Materials | (9) | (3) | (1) | — | (13) | ||||||||||||||||||||||||
| Acetate Tow | (8) | — | — | — | (8) | ||||||||||||||||||||||||
| Acetyl Chain | (4) | (13) | (1) | — | (18) | ||||||||||||||||||||||||
| Total Company | (6) | (8) | (1) | — | (15) | ||||||||||||||||||||||||
Three Months Ended September 30, 2019 Compared to Three Months Ended September 30, 2018
| Volume | Price | Currency | Other | Total | |||||||||||||||||||||||||
| (In percentages) | |||||||||||||||||||||||||||||
| Engineered Materials | (4) | (2) | (2) | — | (8) | ||||||||||||||||||||||||
| Acetate Tow | — | — | — | — | — | ||||||||||||||||||||||||
| Acetyl Chain | 6 | (18) | (2) | — | (14) | ||||||||||||||||||||||||
| Total Company | 2 | (11) | (2) | 1 | (10) | ||||||||||||||||||||||||
Three Months Ended June 30, 2019 Compared to Three Months Ended June 30, 2018
| Volume | Price | Currency | Other | Total | |||||||||||||||||||||||||
| (In percentages) | |||||||||||||||||||||||||||||
| Engineered Materials | (8) | — | (3) | — | (11) | ||||||||||||||||||||||||
| Acetate Tow | 1 | 1 | (1) | — | 1 | ||||||||||||||||||||||||
| Acetyl Chain | (1) | (14) | (3) | — | (18) | ||||||||||||||||||||||||
| Total Company | (3) | (8) | (3) | — | (14) | ||||||||||||||||||||||||
Three Months Ended March 31, 2019 Compared to Three Months Ended March 31, 2018
| Volume | Price | Currency | Other | Total | |||||||||||||||||||||||||
| (In percentages) | |||||||||||||||||||||||||||||
| Engineered Materials | (3) | 7 | (4) | — | — | ||||||||||||||||||||||||
| Acetate Tow | (1) | — | — | — | (1) | ||||||||||||||||||||||||
| Acetyl Chain | (4) | (8) | (3) | — | (15) | ||||||||||||||||||||||||
| Total Company | (3) | (2) | (4) | — | (9) | ||||||||||||||||||||||||
11
Table 4c
Factors Affecting Segment Net Sales Year Over Year - Unaudited
Year Ended December 31, 2020 Compared to Year Ended December 31, 2019
| Volume | Price | Currency | Other | Total | |||||||||||||||||||||||||
| (In percentages) | |||||||||||||||||||||||||||||
| Engineered Materials | (11) | (3) | 1 | — | (13) | ||||||||||||||||||||||||
| Acetate Tow | (14) | (4) | — | — | (18) | ||||||||||||||||||||||||
| Acetyl Chain | — | (8) | 1 | — | (7) | ||||||||||||||||||||||||
| Total Company | (5) | (6) | — | 1 | (10) | ||||||||||||||||||||||||
Year Ended December 31, 2019 Compared to Year Ended December 31, 2018
| Volume | Price | Currency | Other | Total | |||||||||||||||||||||||||
| (In percentages) | |||||||||||||||||||||||||||||
| Engineered Materials | (5) | — | (3) | — | (8) | ||||||||||||||||||||||||
| Acetate Tow | (2) | — | — | — | (2) | ||||||||||||||||||||||||
| Acetyl Chain | (1) | (13) | (2) | — | (16) | ||||||||||||||||||||||||
| Total Company | (3) | (7) | (2) | — | (12) | ||||||||||||||||||||||||
12
Table 5
Free Cash Flow - Reconciliation of a Non-GAAP Measure - Unaudited
| 2020 | 2019 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (In $ millions, except percentages) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net cash provided by (used in) investing activities | 592 | (493) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net cash provided by (used in) financing activities | (1,471) | (935) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net cash provided by (used in) operating activities | 1,343 | 1,454 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Capital expenditures on property, plant and equipment | (364) | (370) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Distributions to NCI | (29) | (10) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Free cash flow(1)(2) | 950 | 1,074 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net sales | 5,655 | 6,297 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Free cash flow as % of Net sales | 16.8 | % | 17.1 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
______________________________
(1)Free cash flow is a liquidity measure used by the Company and is defined by the Company as net cash provided by (used in) operating activities, less capital expenditures on property, plant and equipment, and adjusted for capital contributions or distributions to Mitsui related to our joint venture, Fairway.
(2)Excludes required debt service and finance lease payments of $26 million and $24 million for the years ended December 31, 2020 and 2019, respectively.
13
Table 6
Cash Dividends Received - Unaudited
| 2020 | 2019 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (In $ millions) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends from equity method investments | 147 | 168 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends from equity investments without readily determinable fair values | 126 | 113 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 273 | 281 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Table 7
Net Debt - Reconciliation of a Non-GAAP Measure - Unaudited
| 2020 | 2019 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (In $ millions) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Short-term borrowings and current installments of long-term debt - third party and affiliates | 496 | 496 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Long-term debt, net of unamortized deferred financing costs | 3,227 | 3,409 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total debt | 3,723 | 3,905 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash and cash equivalents | (955) | (463) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net debt | 2,768 | 3,442 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
14
Table 8
Certain Items - Unaudited
The following Certain Items attributable to Celanese Corporation are included in Net earnings (loss) and are adjustments to non-GAAP measures:
| 2020 | 2019 | Income Statement Classification | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (In $ millions) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Plant/office closures | 10 | 26 | Cost of sales / SG&A / Other (charges) gains, net / Gain (loss) on disposition of businesses and assets, net | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Asset impairments | 31 | 94 | (1) | Cost of sales / Other (charges) gains, net | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Clear Lake incident | 4 | 34 | Cost of sales | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| COVID-19 | 5 | — | Cost of sales / SG&A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mergers, acquisitions and dispositions | 22 | 12 | Cost of sales / SG&A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Actuarial (gain) loss on pension and postretirement plans | 95 | 88 | Cost of sales / SG&A / Non-operating pension and other postretirement employee benefit (expense) income | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Restructuring | 25 | 27 | SG&A / Other (charges) gains, net / Non-operating pension and other postretirement employee benefit (expense) income | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| European Commission investigation | 2 | 89 | Other (charges) gains, net | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Commercial disputes | (1) | 10 | Cost of sales / SG&A / Other (charges) gains, net | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (Gain) loss on sale of investments in affiliates | (1,408) | — | Gain (loss) on sale of investments in affiliates | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other | (1) | 1 | SG&A / Gain (loss) on disposition of businesses and assets, net | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Certain Items attributable to Celanese Corporation | (1,216) | 381 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
______________________________
(1)Includes $5 million of asset impairments in 2019 related to the Clear Lake incident.
15
Table 9
Return on Invested Capital (Adjusted) - Presentation of a Non-GAAP Measure - Unaudited
| 2020 | 2019 | ||||||||||||||||||||||||||||||||||
| (In $ millions, except percentages) | |||||||||||||||||||||||||||||||||||
| Net earnings (loss) attributable to Celanese Corporation | 1,985 | 852 | |||||||||||||||||||||||||||||||||
Adjusted EBIT (Table 1) | 1,131 | 1,476 | |||||||||||||||||||||||||||||||||
Adjusted effective tax rate (Table 3a) | 12 | % | 13 | % | |||||||||||||||||||||||||||||||
| Adjusted EBIT tax effected | 995 | 1,284 | |||||||||||||||||||||||||||||||||
| 2020 | 2019 | Average | 2019 | 2018 | Average | ||||||||||||||||||||||||||||||
| (In $ millions, except percentages) | |||||||||||||||||||||||||||||||||||
Short-term borrowings and current installments of long-term debt - third parties and affiliates | 496 | 496 | 496 | 496 | 561 | 529 | |||||||||||||||||||||||||||||
| Long-term debt, net of unamortized deferred financing costs | 3,227 | 3,409 | 3,318 | 3,409 | 2,970 | 3,190 | |||||||||||||||||||||||||||||
| Celanese Corporation stockholders' equity | 3,526 | 2,507 | 3,017 | 2,507 | 2,984 | 2,746 | |||||||||||||||||||||||||||||
| Invested capital | 6,831 | 6,465 | |||||||||||||||||||||||||||||||||
| Return on invested capital (adjusted) | 14.6 | % | 19.9 | % | |||||||||||||||||||||||||||||||
Net earnings (loss) attributable to Celanese Corporation as a percentage of invested capital | 29.1 | % | 13.2 | % | |||||||||||||||||||||||||||||||
16
Exhibit 99.3B
Supplemental Non-US GAAP Financial Measures
March 25, 2021
In this document, the terms the "Company," "we" and "our" refer to Celanese Corporation and its subsidiaries on a consolidated basis.
Purpose
The purpose of this document is to provide information of interest to investors, analysts and other parties including supplemental financial information and reconciliations and other information concerning our use of non-US GAAP financial measures.
Presentation
This document presents the Company's three business segments, Engineered Materials, Acetate Tow and Acetyl Chain.
Use of Non-US GAAP Financial Measures
From time to time, management may publicly disclose certain numerical "non-GAAP financial measures" in the course of our earnings releases, financial presentations, earnings conference calls, investor and analyst meetings and otherwise. For these purposes, the Securities and Exchange Commission ("SEC") defines a "non-GAAP financial measure" as a numerical measure of historical or future financial performance, financial position or cash flows that excludes amounts, or is subject to adjustments that effectively exclude amounts, included in the most directly comparable measure calculated and presented in accordance with US GAAP, and vice versa for measures that include amounts, or are subject to adjustments that effectively include amounts, that are excluded from the most directly comparable US GAAP measure so calculated and presented. For these purposes, "GAAP" refers to generally accepted accounting principles in the United States.
Non-GAAP financial measures disclosed by management are provided as additional information to investors, analysts and other parties because the Company believes them to be important supplemental measures for assessing our financial and operating results and as a means to evaluate our financial condition and period-to-period comparisons. These non-GAAP financial measures should be viewed as supplemental to, and should not be considered in isolation or as alternatives to, net earnings (loss), operating profit (loss), operating margin, cash flow from operating activities (together with cash flow from investing and financing activities), earnings per share or any other US GAAP financial measure. These non-GAAP financial measures should be considered within the context of our complete audited and unaudited financial results for the given period, which are available on the Financial Information/Financial Document Library page of our website, investors.celanese.com. The definition and method of calculation of the non-GAAP financial measures used herein may be different from other companies' methods for calculating measures with the same or similar titles. Investors, analysts and other parties should understand how another company calculates such non-GAAP financial measures before comparing the other company's non-GAAP financial measures to any of our own. These non-GAAP financial measures may not be indicative of the historical operating results of the Company nor are they intended to be predictive or projections of future results.
Pursuant to the requirements of SEC Regulation G, whenever we refer to a non-GAAP financial measure, we will also present in this document, in the presentation itself or on a Form 8-K in connection with the presentation on the Financial Information/Financial Document Library page of our website, investors.celanese.com, to the extent practicable, the most directly comparable financial measure calculated and presented in accordance with GAAP, along with a reconciliation of the differences between the non-GAAP financial measure we reference and such comparable GAAP financial measure.
This document includes definitions and reconciliations of non-GAAP financial measures used from time to time by the Company.
Specific Measures Used
This document provides information about the following non-GAAP measures: adjusted EBIT, adjusted EBIT margin, operating EBITDA, operating EBITDA margin, operating profit (loss) attributable to Celanese Corporation, adjusted earnings per share, net debt, free cash flow and return on invested capital (adjusted). The most directly comparable financial measure presented in accordance with US GAAP in our consolidated financial statements for adjusted EBIT and operating EBITDA is net earnings (loss) attributable to Celanese Corporation; for adjusted EBIT margin and operating EBITDA margin is operating margin; for operating profit (loss) attributable to Celanese Corporation is operating profit (loss); for adjusted earnings per share is earnings (loss) from continuing operations attributable to Celanese Corporation per common share-diluted; for net debt
1
is total debt; for free cash flow is net cash provided by (used in) operations; and for return on invested capital (adjusted) is net earnings (loss) attributable to Celanese Corporation divided by the sum of the average of beginning and end of the year short- and long-term debt and Celanese Corporation stockholders' equity.
Definitions
•Adjusted EBIT is a performance measure used by the Company and is defined by the Company as net earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income, plus interest expense, plus refinancing expense and taxes, and further adjusted for Certain Items (refer to Table 8). We believe that adjusted EBIT provides transparent and useful information to management, investors, analysts and other parties in evaluating and assessing our primary operating results from period-to-period after removing the impact of unusual, non-operational or restructuring-related activities that affect comparability. Our management recognizes that adjusted EBIT has inherent limitations because of the excluded items. Adjusted EBIT is one of the measures management uses for planning and budgeting, monitoring and evaluating financial and operating results and as a performance metric in the Company's incentive compensation plan. We do not provide reconciliations for adjusted EBIT on a forward-looking basis (including those contained in this document) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of Certain Items, such as mark-to-market pension gains and losses, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information. Adjusted EBIT margin is defined by the Company as adjusted EBIT divided by net sales. Adjusted EBIT margin has the same uses and limitations as Adjusted EBIT.
•Operating EBITDA is a performance measure used by the Company and is defined by the Company as net earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income, plus interest expense, plus refinancing expense, taxes and depreciation and amortization, and further adjusted for Certain Items, which Certain Items include accelerated depreciation and amortization expense. Operating EBITDA is equal to adjusted EBIT plus depreciation and amortization. We believe that Operating EBITDA provides transparent and useful information to investors, analysts and other parties in evaluating our operating performance relative to our peer companies. Operating EBITDA margin is defined by the Company as Operating EBITDA divided by net sales. Operating EBITDA margin has the same uses and limitations as Operating EBITDA.
•Operating profit (loss) attributable to Celanese Corporation is defined by the Company as operating profit (loss), less earnings (loss) attributable to noncontrolling interests ("NCI"). We believe that operating profit (loss) attributable to Celanese Corporation provides transparent and useful information to management, investors, analysts and other parties in evaluating our core operational performance. Operating margin attributable to Celanese Corporation is defined by the Company as operating profit (loss) attributable to Celanese Corporation divided by net sales. Operating margin attributable to Celanese Corporation has the same uses and limitations as Operating profit (loss) attributable to Celanese Corporation.
•Adjusted earnings per share is a performance measure used by the Company and is defined by the Company as earnings (loss) from continuing operations attributable to Celanese Corporation, adjusted for income tax (provision) benefit, Certain Items, and refinancing and related expenses, divided by the number of basic common shares and dilutive restricted stock units and stock options calculated using the treasury method. We believe that adjusted earnings per share provides transparent and useful information to management, investors, analysts and other parties in evaluating and assessing our primary operating results from period-to-period after removing the impact of the above stated items that affect comparability and as a performance metric in the Company's incentive compensation plan. We do not provide reconciliations for adjusted earnings per share on a forward-looking basis (including those contained in this document) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of Certain Items, such as mark-to-market pension gains and losses, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information.
Note: The income tax expense (benefit) on Certain Items ("Non-GAAP adjustments") is determined using the applicable rates in the taxing jurisdictions in which the Non-GAAP adjustments occurred and includes both current and deferred income tax expense (benefit). The income tax rate used for adjusted earnings per share approximates the midpoint in a range of forecasted tax rates for the year. This range may include certain partial or full-year forecasted tax opportunities and related costs, where applicable, and specifically excludes changes in uncertain tax positions, discrete recognition of GAAP items on a quarterly basis, other pre-tax items adjusted out of our GAAP earnings for adjusted earnings per share purposes and changes in management's assessments regarding the ability to realize deferred tax assets for GAAP. In determining the adjusted earnings per share tax rate, we reflect the impact of foreign tax credits when utilized, or expected to be utilized, absent discrete events impacting the timing of foreign tax credit utilization. We analyze this rate quarterly and adjust it if there is a material change in the range of forecasted tax rates; an updated forecast would not necessarily result in a change to our tax rate used for adjusted earnings per share. The adjusted tax rate is an estimate and may differ from the actual tax rate used for GAAP reporting in any given reporting period. Table 3a summarizes the reconciliation of our GAAP effective tax rate to the adjusted tax rate.
•Free cash flow is a liquidity measure used by the Company and is defined by the Company as net cash provided by (used in) operations, less capital expenditures on property, plant and equipment, and adjusted for capital contributions from or distributions to Mitsui & Co., Ltd. ("Mitsui") related to our methanol joint venture, Fairway Methanol LLC ("Fairway"). We believe that free cash flow provides useful information to
2
management, investors, analysts and other parties in evaluating the Company's liquidity and credit quality assessment because it provides an indication of the long-term cash generating ability of our business. Although we use free cash flow as a measure to assess the liquidity generated by our business, the use of free cash flow has important limitations, including that free cash flow does not reflect the cash requirements necessary to service our indebtedness, lease obligations, unconditional purchase obligations or pension and postretirement funding obligations.
•Net debt is defined by the Company as total debt less cash and cash equivalents. We believe that net debt provides useful information to management, investors, analysts and other parties in evaluating changes to the Company's capital structure and credit quality assessment.
•Return on invested capital (adjusted) is defined by the Company as adjusted EBIT, tax effected using the adjusted tax rate, divided by the sum of the average of beginning and end of the year short- and long-term debt and Celanese Corporation stockholders' equity. We believe that return on invested capital (adjusted) provides useful information to management, investors, analysts and other parties in order to assess our income generation from the point of view of our stockholders and creditors who provide us with capital in the form of equity and debt and whether capital invested in the Company yields competitive returns.
Supplemental Information
Supplemental Information we believe to be of interest to investors, analysts and other parties includes the following:
•Net sales for each of our business segments.
•Cash dividends received from our equity investments.
•For those consolidated ventures in which the Company owns or is exposed to less than 100% of the economics, the outside stockholders' interests are shown as NCI. Beginning in 2014, this includes Fairway for which the Company's ownership percentage is 50%. Amounts referred to as "attributable to Celanese Corporation" are net of any applicable NCI.
Results Unaudited
The results in this document, together with the adjustments made to present the results on a comparable basis, have not been audited and are based on internal financial data furnished to management. Quarterly results should not be taken as an indication of the results of operations to be reported for any subsequent period or for the full fiscal year.
3
Table 1
Adjusted EBIT and Operating EBITDA - Reconciliation of Non-GAAP Measures - Unaudited
| 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||||||||||||||||||||||||||||||||||||||||
| (In $ millions) | |||||||||||||||||||||||||||||||||||||||||||||||
Net earnings (loss) attributable to Celanese Corporation | 1,207 | 843 | 900 | 304 | 624 | 1,101 | 372 | 427 | |||||||||||||||||||||||||||||||||||||||
(Earnings) loss from discontinued operations | 5 | 13 | 2 | 2 | 7 | — | 4 | (1) | |||||||||||||||||||||||||||||||||||||||
| Interest income | (6) | (2) | (2) | (1) | (1) | (1) | (2) | (3) | |||||||||||||||||||||||||||||||||||||||
| Interest expense | 125 | 122 | 120 | 119 | 147 | 172 | 185 | 221 | |||||||||||||||||||||||||||||||||||||||
| Refinancing expense | 1 | — | 6 | — | 29 | 1 | 3 | 3 | |||||||||||||||||||||||||||||||||||||||
| Income tax provision (benefit) | 292 | 213 | 122 | 201 | 314 | 508 | (55) | 41 | |||||||||||||||||||||||||||||||||||||||
Certain Items attributable to Celanese Corporation (Table 8) | 228 | 167 | 130 | 611 | 148 | (725) | 455 | 405 | |||||||||||||||||||||||||||||||||||||||
| Adjusted EBIT | 1,852 | 1,356 | 1,278 | 1,236 | 1,268 | 1,056 | 962 | 1,093 | |||||||||||||||||||||||||||||||||||||||
Depreciation and amortization expense(1) | 316 | 303 | 288 | 279 | 290 | 302 | 300 | 287 | |||||||||||||||||||||||||||||||||||||||
| Operating EBITDA | 2,168 | 1,659 | 1,566 | 1,515 | 1,558 | 1,358 | 1,262 | 1,380 | |||||||||||||||||||||||||||||||||||||||
| 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||||||||||||||||||||||||||||||||||||||||
| (In $ millions) | |||||||||||||||||||||||||||||||||||||||||||||||
| Engineered Materials | 1 | — | — | — | — | — | — | 3 | |||||||||||||||||||||||||||||||||||||||
| Acetate Tow | 19 | — | 1 | 10 | — | — | 6 | 8 | |||||||||||||||||||||||||||||||||||||||
| Acetyl Chain | 7 | 2 | — | 68 | 2 | 3 | 2 | — | |||||||||||||||||||||||||||||||||||||||
Other Activities(2) | — | — | 1 | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||
Accelerated depreciation and amortization expense | 27 | 2 | 2 | 78 | 2 | 3 | 8 | 11 | |||||||||||||||||||||||||||||||||||||||
Depreciation and amortization expense(1) | 316 | 303 | 288 | 279 | 290 | 302 | 300 | 287 | |||||||||||||||||||||||||||||||||||||||
Total depreciation and amortization expense | 343 | 305 | 290 | 357 | 292 | 305 | 308 | 298 | |||||||||||||||||||||||||||||||||||||||
______________________________
(1)Excludes accelerated depreciation and amortization expense as detailed in the table above, which amounts are included in Certain Items above.
(2)Other Activities includes corporate Selling, general and administrative ("SG&A") expenses, the results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).
4
| Table 2 - Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating EBITDA - Non-GAAP Measures - Unaudited | | ||||||||||
| 2018 | 2017 | 2016 | 2015 | 2014 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (In $ millions, except percentages) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Operating Profit (Loss) / Operating Margin | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Engineered Materials | 460 | 17.7 | % | 412 | 18.6 | % | 377 | 24.3 | % | 264 | 18.4 | % | 187 | 11.8 | % | ||||||||||||||||||||||||||||||||||||||||||||
Acetate Tow | 130 | 20.0 | % | 189 | 28.3 | % | 276 | 33.6 | % | 233 | 27.1 | % | 336 | 32.5 | % | ||||||||||||||||||||||||||||||||||||||||||||
Acetyl Chain(1) | 1,024 | 25.3 | % | 509 | 15.1 | % | 444 | 14.2 | % | 67 | 1.9 | % | 586 | 13.6 | % | ||||||||||||||||||||||||||||||||||||||||||||
Other Activities(2) | (280) | (253) | (163) | (179) | (204) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 1,334 | 18.6 | % | 857 | 14.0 | % | 934 | 17.3 | % | 385 | 6.8 | % | 905 | 13.3 | % | ||||||||||||||||||||||||||||||||||||||||||||
Less: Net Earnings (Loss) Attributable to NCI(1) | 6 | 6 | 6 | (19) | (4) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Operating Profit (Loss) Attributable to Celanese Corporation | 1,328 | 18.6 | % | 851 | 13.9 | % | 928 | 17.2 | % | 404 | 7.1 | % | 909 | 13.4 | % | ||||||||||||||||||||||||||||||||||||||||||||
Operating Profit (Loss) / Operating Margin Attributable to Celanese Corporation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Engineered Materials | 460 | 17.7 | % | 412 | 18.6 | % | 377 | 24.3 | % | 264 | 18.4 | % | 187 | 11.8 | % | ||||||||||||||||||||||||||||||||||||||||||||
| Acetate Tow | 130 | 20.0 | % | 189 | 28.3 | % | 276 | 33.6 | % | 233 | 27.1 | % | 336 | 32.5 | % | ||||||||||||||||||||||||||||||||||||||||||||
Acetyl Chain(1) | 1,018 | 25.2 | % | 503 | 14.9 | % | 438 | 14.0 | % | 86 | 2.5 | % | 590 | 13.7 | % | ||||||||||||||||||||||||||||||||||||||||||||
Other Activities(2) | (280) | (253) | (163) | (179) | (204) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 1,328 | 18.6 | % | 851 | 13.9 | % | 928 | 17.2 | % | 404 | 7.1 | % | 909 | 13.4 | % | ||||||||||||||||||||||||||||||||||||||||||||
Equity Earnings and Dividend Income, Other Income (Expense) Attributable to Celanese Corporation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Engineered Materials | 219 | (3) | 171 | 125 | 153 | 170 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acetate Tow | 116 | 107 | 107 | 106 | 115 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acetyl Chain | 8 | 6 | 7 | 7 | 21 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Activities(2) | 15 | 10 | 22 | 14 | 52 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 358 | 294 | 261 | 280 | 358 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Non-Operating Pension and Other Post-Retirement Employee Benefit (Expense) Income Attributable to Celanese Corporation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Engineered Materials | — | — | (1) | — | 54 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acetate Tow | — | — | — | — | 32 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acetyl Chain | — | 2 | 2 | 2 | 48 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Activities(2) | (62) | 42 | (42) | (61) | (281) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | (62) | 44 | (41) | (59) | (147) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Certain Items Attributable to Celanese Corporation (Table 8) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Engineered Materials | 15 | 16 | 8 | 11 | (59) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acetate Tow | 27 | 5 | 5 | 41 | (46) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acetyl Chain | (4) | 64 | 7 | 403 | (48) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Activities(2) | 190 | 82 | 110 | 156 | 301 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 228 | 167 | 130 | 611 | 148 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adjusted EBIT / Adjusted EBIT Margin | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Engineered Materials | 694 | 26.8 | % | 599 | 27.1 | % | 509 | 32.8 | % | 428 | 29.8 | % | 352 | 22.2 | % | ||||||||||||||||||||||||||||||||||||||||||||
| Acetate Tow | 273 | 42.1 | % | 301 | 45.1 | % | 388 | 47.3 | % | 380 | 44.1 | % | 437 | 42.3 | % | ||||||||||||||||||||||||||||||||||||||||||||
| Acetyl Chain | 1,022 | 25.3 | % | 575 | 17.1 | % | 454 | 14.5 | % | 498 | 14.2 | % | 611 | 14.2 | % | ||||||||||||||||||||||||||||||||||||||||||||
Other Activities(2) | (137) | (119) | (73) | (70) | (132) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 1,852 | 25.9 | % | 1,356 | 22.1 | % | 1,278 | 23.7 | % | 1,236 | 21.8 | % | 1,268 | 18.6 | % | ||||||||||||||||||||||||||||||||||||||||||||
___________________________
(1)Net earnings (loss) attributable to NCI is included within the Acetyl Chain segment.
(2)Other Activities includes corporate SG&A expenses, the results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).
(3)Includes $218 million of Equity in net earnings (loss) of affiliates and $1 million of Other income.
5
| Table 2 - Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating EBITDA - Non-GAAP Measures - Unaudited | | ||||||||||
| 2018 | 2017 | 2016 | 2015 | 2014 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (In $ millions, except percentages) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Depreciation and Amortization Expense(1) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Engineered Materials | 125 | 111 | 95 | 103 | 111 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acetate Tow | 39 | 41 | 41 | 46 | 38 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acetyl Chain | 141 | 141 | 141 | 119 | 129 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Activities(2) | 11 | 10 | 11 | 11 | 12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 316 | 303 | 288 | 279 | 290 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Operating EBITDA / Operating EBITDA Margin | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Engineered Materials | 819 | 31.6 | % | 710 | 32.1 | % | 604 | 38.9 | % | 531 | 37.0 | % | 463 | 29.2 | % | ||||||||||||||||||||||||||||||||||||||||||||
| Acetate Tow | 312 | 48.1 | % | 342 | 51.2 | % | 429 | 52.3 | % | 426 | 49.5 | % | 475 | 46.0 | % | ||||||||||||||||||||||||||||||||||||||||||||
| Acetyl Chain | 1,163 | 28.8 | % | 716 | 21.2 | % | 595 | 19.0 | % | 617 | 17.6 | % | 740 | 17.2 | % | ||||||||||||||||||||||||||||||||||||||||||||
Other Activities(2) | (126) | (109) | (62) | (59) | (120) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 2,168 | 30.3 | % | 1,659 | 27.0 | % | 1,566 | 29.1 | % | 1,515 | 26.7 | % | 1,558 | 22.9 | % | ||||||||||||||||||||||||||||||||||||||||||||
___________________________
(1)Excludes accelerated depreciation and amortization expense, which amounts are included in Certain Items above. See Table 1 for details.
(2)Other Activities includes corporate SG&A expenses, the results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).
6
Table 3
Adjusted Earnings (Loss) per Share - Reconciliation of a Non-GAAP Measure - Unaudited
| 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| per share | per share | per share | per share | per share | per share | per share | per share | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (In $ millions, except per share data) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings (loss) from continuing operations attributable to Celanese Corporation | 1,212 | 8.95 | 856 | 6.19 | 902 | 6.19 | 306 | 2.01 | 631 | 4.04 | 1,101 | 6.91 | 376 | 2.35 | 426 | 2.68 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income tax provision (benefit) | 292 | 213 | 122 | 201 | 314 | 508 | (55) | 41 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings (loss) from continuing operations before tax | 1,504 | 1,069 | 1,024 | 507 | 945 | 1,609 | 321 | 467 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Certain Items attributable to Celanese Corporation (Table 8) | 228 | 167 | 130 | 611 | 148 | (725) | 455 | 405 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refinancing and related expenses | 1 | — | 6 | — | 29 | 1 | 8 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adjusted earnings (loss) from continuing operations before tax | 1,733 | 1,236 | 1,160 | 1,118 | 1,122 | 885 | 784 | 875 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income tax (provision) benefit on adjusted earnings(1) | (243) | (198) | (197) | (201) | (236) | (168) | (133) | (158) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adjusted earnings (loss) from continuing operations(2) | 1,490 | 11.00 | 1,038 | 7.51 | 963 | 6.61 | 917 | 6.02 | 886 | 5.67 | 717 | 4.50 | 651 | 4.07 | 717 | 4.51 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Diluted shares (in millions)(3) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Weighted average shares outstanding | 134.3 | 137.9 | 144.9 | 150.8 | 155.0 | 158.8 | 158.4 | 156.2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Incremental shares attributable to equity awards | 1.1 | 0.4 | 0.8 | 1.5 | 1.2 | 0.5 | 1.4 | 2.7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total diluted shares | 135.4 | 138.3 | 145.7 | 152.3 | 156.2 | 159.3 | 159.8 | 158.9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
______________________________
(1)Calculated using adjusted effective tax rates (Table 3a) as follows:
| 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (In percentages) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adjusted effective tax rate | 14 | 16 | 17 | 18 | 21 | 19 | 17 | 18 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(2)Excludes the immediate recognition of actuarial gains and losses and the impact of actual vs. expected plan asset returns.
| Actual Plan Asset Returns | Expected Plan Asset Returns | |||||||||||||
| (In percentages) | ||||||||||||||
| 2018 | (3.9) | 6.7 | ||||||||||||
| 2017 | 10.5 | 7.3 | ||||||||||||
| 2016 | 6.9 | 7.3 | ||||||||||||
| 2015 | (2.5) | 7.8 | ||||||||||||
| 2014 | 12.7 | 8.2 | ||||||||||||
| 2013 | 7.9 | 8.0 | ||||||||||||
| 2012 | 13.1 | 8.1 | ||||||||||||
| 2011 | 7.6 | 8.1 | ||||||||||||
(3)Potentially dilutive shares are included in the adjusted earnings per share calculation when adjusted earnings are positive.
7
Table 3a
Adjusted Tax Rate - Reconciliation of a Non-GAAP Measure - Unaudited
| Actual | |||||||||||||||||||||||||||||||||||||||||||||||
| 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||||||||||||||||||||||||||||||||||||||||
| (In percentages) | |||||||||||||||||||||||||||||||||||||||||||||||
| US GAAP effective tax rate | 19 | 20 | 12 | 41 | 33 | 32 | (17) | 9 | |||||||||||||||||||||||||||||||||||||||
Discrete quarterly recognition of GAAP items(1) | — | (11) | 1 | 2 | (6) | (6) | (7) | 2 | |||||||||||||||||||||||||||||||||||||||
Tax impact of other charges and adjustments(2) | — | 1 | 3 | (15) | — | — | 29 | 8 | |||||||||||||||||||||||||||||||||||||||
| Utilization/generation of foreign tax credits | — | 20 | — | (2) | (3) | (5) | 16 | — | |||||||||||||||||||||||||||||||||||||||
Changes in valuation allowances, excluding impact of other charges and adjustments(3) | (5) | (13) | 2 | (5) | (3) | (1) | (3) | — | |||||||||||||||||||||||||||||||||||||||
Other(4) | — | (1) | (1) | (3) | — | (1) | (1) | (1) | |||||||||||||||||||||||||||||||||||||||
| Adjusted tax rate | 14 | 16 | 17 | 18 | 21 | 19 | 17 | 18 | |||||||||||||||||||||||||||||||||||||||
______________________________
(1)Such as changes in tax laws (including US tax reform), deferred taxes on outside basis differences, changes in uncertain tax positions and prior year audit adjustments.
(2)Reflects the tax impact on pre-tax adjustments presented in Certain Items (Table 8), which are excluded from pre-tax income for adjusted earnings per share purposes.
(3)Reflects changes in valuation allowances related to changes in judgment regarding the realizability of deferred tax assets or current year operations, excluding other charges and adjustments.
(4)Tax impacts related to full-year forecasted tax opportunities and related costs.
8
Table 4
Net Sales by Segment - Unaudited
| 2018 | 2017 | 2016 | 2015 | 2014 | |||||||||||||||||||||||||||||||||||||||||||
| (In $ millions) | |||||||||||||||||||||||||||||||||||||||||||||||
| Engineered Materials | 2,593 | 2,213 | 1,552 | 1,434 | 1,586 | ||||||||||||||||||||||||||||||||||||||||||
| Acetate Tow | 649 | 668 | 821 | 861 | 1,033 | ||||||||||||||||||||||||||||||||||||||||||
| Acetyl Chain | 4,042 | 3,371 | 3,132 | 3,503 | 4,306 | ||||||||||||||||||||||||||||||||||||||||||
Intersegment eliminations(2) | (129) | (112) | (116) | (124) | (123) | ||||||||||||||||||||||||||||||||||||||||||
| Net sales | 7,155 | 6,140 | 5,389 | 5,674 | 6,802 | ||||||||||||||||||||||||||||||||||||||||||
___________________________
(1)Other Activities includes corporate SG&A expenses, the results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).
(2)Includes intersegment sales primarily related to the Acetyl Chain.
9
Table 5
Free Cash Flow - Reconciliation of a Non-GAAP Measure - Unaudited
| 2018 | 2017 | 2016 | 2015 | 2014 | |||||||||||||||||||||||||||||||||||||||||||
| (In $ millions) | |||||||||||||||||||||||||||||||||||||||||||||||
| Net cash provided by (used in) investing activities | (507) | (549) | (439) | (558) | (705) | ||||||||||||||||||||||||||||||||||||||||||
| Net cash provided by (used in) financing activities | (1,165) | (351) | (759) | (66) | (415) | ||||||||||||||||||||||||||||||||||||||||||
| Net cash provided by (used in) operating activities | 1,558 | 803 | 893 | 862 | 962 | ||||||||||||||||||||||||||||||||||||||||||
| Capital expenditures on property, plant and equipment | (337) | (267) | (246) | (520) | (678) | ||||||||||||||||||||||||||||||||||||||||||
Capital (distributions to) contributions from NCI | (23) | (27) | (24) | 214 | 264 | ||||||||||||||||||||||||||||||||||||||||||
Free cash flow(1)(2) | 1,198 | 509 | 623 | 556 | 548 | ||||||||||||||||||||||||||||||||||||||||||
______________________________
(1)Free cash flow is a liquidity measure used by the Company and is defined by the Company as net cash provided by (used in) operating activities, less capital expenditures on property, plant and equipment, and adjusted for capital contributions from or distributions to Mitsui & Co., Ltd. ("Mitsui") related to our joint venture, Fairway Methanol LLC ("Fairway").
(2)Excludes required debt service and finance lease payments of $63 million, $27 million, $56 million, $25 million and $24 million for the years ended December 31, 2018, 2017, 2016, 2015 and 2014, respectively.
10
Table 6
Cash Dividends Received - Unaudited
| 2018 | 2017 | 2016 | 2015 | 2014 | |||||||||||||||||||||||||||||||||||||||||||
| (In $ millions) | |||||||||||||||||||||||||||||||||||||||||||||||
| Dividends from equity method investments | 221 | 131 | 131 | 176 | 148 | ||||||||||||||||||||||||||||||||||||||||||
| Dividends from equity investments without readily determinable fair values | 117 | 108 | 108 | 107 | 116 | ||||||||||||||||||||||||||||||||||||||||||
| Total | 338 | 239 | 239 | 283 | 264 | ||||||||||||||||||||||||||||||||||||||||||
Table 7
Net Debt - Reconciliation of a Non-GAAP Measure - Unaudited
| 2018 | 2017 | 2016 | 2015 | 2014 | |||||||||||||||||||||||||||||||||||||||||||
| (In $ millions) | |||||||||||||||||||||||||||||||||||||||||||||||
Short-term borrowings and current installments of long-term debt - third party and affiliates | 561 | 326 | 118 | 513 | 137 | ||||||||||||||||||||||||||||||||||||||||||
| Long-term debt, net of unamortized deferred financing costs | 2,970 | 3,315 | 2,890 | 2,468 | 2,586 | ||||||||||||||||||||||||||||||||||||||||||
| Total debt | 3,531 | 3,641 | 3,008 | 2,981 | 2,723 | ||||||||||||||||||||||||||||||||||||||||||
| Cash and cash equivalents | (439) | (576) | (638) | (967) | (780) | ||||||||||||||||||||||||||||||||||||||||||
| Net debt | 3,092 | 3,065 | 2,370 | 2,014 | 1,943 | ||||||||||||||||||||||||||||||||||||||||||
11
Table 8
Certain Items - Unaudited
The following Certain Items attributable to Celanese Corporation are included in Net earnings (loss) and are adjustments to non-GAAP measures:
| 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | Income Statement Classification | |||||||||||||||||||||||||||||||||||||||||||||
| (In $ millions) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Plant/office closures | 19 | 58 | 4 | 48 | 6 | 43 | 21 | 18 | Cost of sales / SG&A / R&D / Other (charges) gains, net / Gain (loss) on disposition of businesses and assets, net | ||||||||||||||||||||||||||||||||||||||||||||
| Asset impairments | — | — | 6 | 165 | 5 | 83 | 8 | — | Cost of sales / R&D / Other (charges) gains, net | ||||||||||||||||||||||||||||||||||||||||||||
| Mergers and acquisitions | 33 | 35 | 3 | — | — | — | — | — | Cost of sales / SG&A / Other income (expense), net | ||||||||||||||||||||||||||||||||||||||||||||
| Actuarial (gain) loss on pension and postretirement plans | 166 | 46 | 102 | 127 | 349 | (106) | 389 | 306 | Cost of sales / SG&A / Non-operating pension and other postretirement employee benefit (expense) income | ||||||||||||||||||||||||||||||||||||||||||||
| Restructuring | 9 | 9 | 19 | 77 | (140) | (40) | 15 | 30 | Cost of sales / SG&A / Other (charges) gains, net / Non-operating pension and other postretirement employee benefit (expense) income | ||||||||||||||||||||||||||||||||||||||||||||
Impact from natural disasters(1) | — | 11 | — | — | — | — | — | — | Cost of sales | ||||||||||||||||||||||||||||||||||||||||||||
InfraServ ownership change | — | 8 | — | — | — | — | — | — | Other (charges) gains, net / Equity in net earnings (loss) of affiliates | ||||||||||||||||||||||||||||||||||||||||||||
InfraServ debt restructuring | — | — | — | — | (48) | — | (22) | — | Equity in net earnings (loss) of affiliates | ||||||||||||||||||||||||||||||||||||||||||||
| Singapore contract termination | — | — | — | 174 | — | — | — | — | Other (charges) gains, net | ||||||||||||||||||||||||||||||||||||||||||||
Commercial disputes(2) | — | — | (2) | 6 | (11) | 12 | (7) | (13) | Cost of sales / Other (charges) gains, net | ||||||||||||||||||||||||||||||||||||||||||||
Start-up costs(3) | — | — | 2 | 10 | — | — | — | — | Cost of sales | ||||||||||||||||||||||||||||||||||||||||||||
| Kelsterbach plant relocation | — | — | — | — | (1) | (727) | 21 | 55 | Gain (loss) on disposition of businesses and assets, net | ||||||||||||||||||||||||||||||||||||||||||||
Acetate production interruption costs | — | — | — | — | — | — | 10 | — | Cost of sales | ||||||||||||||||||||||||||||||||||||||||||||
| Other | 1 | — | (4) | 4 | (12) | 10 | 20 | 9 | Cost of sales / SG&A / Gain (loss) on disposition, net / Equity in net earnings (loss) of affiliates | ||||||||||||||||||||||||||||||||||||||||||||
| Certain Items attributable to Celanese Corporation | 228 | 167 | 130 | 611 | 148 | (725) | 455 | 405 | |||||||||||||||||||||||||||||||||||||||||||||
______________________________
(1)Primarily associated with Hurricane Harvey.
(2)Primarily associated with litigation settlement costs.
(3)Primarily associated with Fairway joint venture operational start-up costs.
12
Table 9
Return on Invested Capital (Adjusted) - Presentation of a Non-GAAP Measure - Unaudited
| 2018 | 2017 | 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (In $ millions, except percentages) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net earnings (loss) attributable to Celanese Corporation | 1,207 | 843 | 900 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adjusted EBIT (Table 1) | 1,852 | 1,356 | 1,278 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adjusted effective tax rate (Table 3a) | 14 | % | 16 | % | 17 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjusted EBIT tax effected | 1,593 | 1,139 | 1,061 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2018 | 2017 | Average | 2017 | 2016 | Average | 2016 | 2015 | Average | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (In $ millions, except percentages) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Short-term borrowings and current installments of long-term debt - third parties and affiliates | 561 | 326 | 444 | 326 | 118 | 222 | 118 | 513 | 316 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Long-term debt, net of unamortized deferred financing costs | 2,970 | 3,315 | 3,143 | 3,315 | 2,890 | 3,103 | 2,890 | 2,468 | 2,679 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Celanese Corporation stockholders' equity | 2,984 | 2,887 | 2,936 | 2,887 | 2,588 | 2,738 | 2,588 | 2,378 | 2,483 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Invested capital | 6,523 | 6,063 | 5,478 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Return on invested capital (adjusted) | 24.4 | % | 18.8 | % | 19.4 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net earnings (loss) attributable to Celanese Corporation as a percentage of invested capital | 18.5 | % | 13.9 | % | 16.4 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
13
Table 9
Return on Invested Capital (Adjusted) - Presentation of a Non-GAAP Measure - Unaudited
| 2015 | 2014 | ||||||||||||||||||||||||||||||||||
| (In $ millions, except percentages) | |||||||||||||||||||||||||||||||||||
| Net earnings (loss) attributable to Celanese Corporation | 304 | 624 | |||||||||||||||||||||||||||||||||
Adjusted EBIT (Table 1) | 1,236 | 1,268 | |||||||||||||||||||||||||||||||||
Adjusted effective tax rate (Table 3a) | 18 | % | 21 | % | |||||||||||||||||||||||||||||||
| Adjusted EBIT tax effected | 1,014 | 1,002 | |||||||||||||||||||||||||||||||||
| 2015 | 2014 | Average | 2014 | 2013 | Average | ||||||||||||||||||||||||||||||
| (In $ millions, except percentages) | |||||||||||||||||||||||||||||||||||
Short-term borrowings and current installments of long-term debt - third parties and affiliates | 513 | 137 | 325 | 137 | 177 | 157 | |||||||||||||||||||||||||||||
| Long-term debt, net of unamortized deferred financing costs | 2,468 | 2,586 | 2,527 | 2,586 | 2,863 | 2,725 | |||||||||||||||||||||||||||||
| Celanese Corporation stockholders' equity | 2,378 | 2,818 | 2,598 | 2,818 | 2,699 | 2,759 | |||||||||||||||||||||||||||||
| Invested capital | 5,450 | 5,641 | |||||||||||||||||||||||||||||||||
| Return on invested capital (adjusted) | 18.6 | % | 17.8 | % | |||||||||||||||||||||||||||||||
| Net earnings (loss) attributable to Celanese Corporation as a percentage of invested capital | 5.6 | % | 11.1 | % | |||||||||||||||||||||||||||||||
14